{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:38Z","timestamp":1792788338980,"version":"4.5.0"},"reference-count":284,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300675"],"award-info":[{"award-number":["32300675"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400598"],"award-info":[{"award-number":["32400598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0615"],"award-info":[{"award-number":["2022YFS0615"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023SYF136"],"award-info":[{"award-number":["2023SYF136"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023JYJ019"],"award-info":[{"award-number":["2023JYJ019"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2025ZNSFSC1019"],"award-info":[{"award-number":["2025ZNSFSC1019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04285-7","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T08:19:56Z","timestamp":1743927596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases"],"prefix":"10.1186","volume":"16","author":[{"given":"Sixiu","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangfan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9433-1641","authenticated-orcid":false,"given":"Bingqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,6]]},"reference":[{"key":"4285_CR1","doi-asserted-by":"crossref","unstructured":"Agnello L, Ciaccio M. Neurodegenerative diseases: from molecular basis to therapy. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms232112854"},{"key":"4285_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cger.2009.12.003","volume":"26","author":"R Tarawneh","year":"2010","unstructured":"Tarawneh R, Galvin JE. Potential future neuroprotective therapies for neurodegenerative disorders and stroke. Clin Geriatr Med. 2010;26:125\u201347.","journal-title":"Clin Geriatr Med"},{"key":"4285_CR3","doi-asserted-by":"publisher","first-page":"149202","DOI":"10.1016\/j.brainres.2024.149202","volume":"1845","author":"R Thapa","year":"2024","unstructured":"Thapa R, Ahmad Bhat A, Shahwan M, Ali H, PadmaPriya G, Bansal P, Rajotiya S, Barwal A, Siva Prasad GV, Pramanik A, Khan A, Hing Goh B, Dureja H, Kumar Singh S, Dua K, Gupta G. Proteostasis disruption and senescence in Alzheimer\u2019s disease pathways to neurodegeneration. Brain Res. 2024;1845:149202.","journal-title":"Brain Res"},{"key":"4285_CR4","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.adj7050","volume":"384","author":"JP de Magalh\u00e3es","year":"2024","unstructured":"de Magalh\u00e3es JP. Cellular senescence in normal physiology. Science. 2024;384:1300\u20131.","journal-title":"Science"},{"key":"4285_CR5","doi-asserted-by":"publisher","first-page":"1162136","DOI":"10.3389\/fcell.2023.1162136","volume":"11","author":"R Farahzadi","year":"2023","unstructured":"Farahzadi R, Valipour B, Montazersaheb S, Fathi E. Targeting the stem cell niche micro-environment as therapeutic strategies in aging. Front Cell Dev Biol. 2023;11:1162136.","journal-title":"Front Cell Dev Biol"},{"key":"4285_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1752-8062.2008.00039.x","volume":"1","author":"TJ Nelson","year":"2008","unstructured":"Nelson TJ, Behfar A, Terzic A. Strategies for therapeutic repair: the R(3) regenerative medicine paradigm. Clin Transl Sci. 2008;1:168\u201371.","journal-title":"Clin Transl Sci"},{"key":"4285_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1126\/science.add6492","volume":"380","author":"KL McKinley","year":"2023","unstructured":"McKinley KL, Longaker MT, Naik S. Emerging frontiers in regenerative medicine. Science. 2023;380:796\u20138.","journal-title":"Science"},{"key":"4285_CR8","doi-asserted-by":"crossref","unstructured":"Zhang P, Sung M-H. Chapter 14 - Cellular senescence in neurodegenerative diseases. In: Serrano M, Mu\u00f1oz-Esp\u00edn D, editors. Cellular senescence in disease. Academic; 2022. pp. 363\u201381.","DOI":"10.1016\/B978-0-12-822514-1.00012-2"},{"key":"4285_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s43587-024-00586-3","volume":"4","author":"IR de Luzy","year":"2024","unstructured":"de Luzy IR, Lee MK, Mobley WC, Studer L. Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration. Nat Aging. 2024;4:309\u201318.","journal-title":"Nat Aging"},{"key":"4285_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.freeradbiomed.2019.01.012","volume":"134","author":"CC Walton","year":"2019","unstructured":"Walton CC, Andersen JK. Unknown fates of (brain) oxidation or UFO: close encounters with neuronal senescence. Free Radic Biol Med. 2019;134:695\u2013701.","journal-title":"Free Radic Biol Med"},{"key":"4285_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.stem.2019.08.013","volume":"25","author":"M Riessland","year":"2019","unstructured":"Riessland M, Kolisnyk B, Kim TW, Cheng J, Ni J, Pearson JA, Park EJ, Dam K, Acehan D, Ramos-Espiritu LS, Wang W, Zhang J, Shim JW, Ciceri G, Brichta L, Studer L, Greengard P. Loss of SATB1 induces p21-Dependent cellular senescence in Post-mitotic dopaminergic neurons. Cell Stem Cell. 2019;25:514\u2013e5308.","journal-title":"Cell Stem Cell"},{"key":"4285_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.14283\/jpad.2022.42","volume":"9","author":"Q Behfar","year":"2022","unstructured":"Behfar Q, Ramirez Zuniga A, Martino-Adami PV. Aging, senescence, and dementia. J Prev Alzheimers Dis. 2022;9:523\u201331.","journal-title":"J Prev Alzheimers Dis"},{"key":"4285_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2020.00016","volume":"14","author":"C Mart\u00ednez-Cu\u00e9","year":"2020","unstructured":"Mart\u00ednez-Cu\u00e9 C, Rueda N. Cellular senescence in neurodegenerative diseases. Front Cell Neurosci. 2020;14:16.","journal-title":"Front Cell Neurosci"},{"key":"4285_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s43587-023-00519-6","volume":"3","author":"J Aguado","year":"2023","unstructured":"Aguado J, Amarilla AA, Taherian Fard A, Albornoz EA, Tyshkovskiy A, Schwabenland M, Chaggar HK, Modhiran N, G\u00f3mez-Incl\u00e1n C, Javed I, Baradar AA, Liang B, Peng L, Dharmaratne M, Pietrogrande G, Padmanabhan P, Freney ME, Parry R, Sng JDJ, Isaacs A, Khromykh AA, Valenzuela Nieto G, Rojas-Fernandez A, Davis TP, Prinz M, Bengsch B, Gladyshev VN, Woodruff TM, Mar JC, Watterson D, Wolvetang EJ. Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology. Nat Aging. 2023;3:1561\u201375.","journal-title":"Nat Aging"},{"key":"4285_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1089\/rej.2018.2155","volume":"21","author":"AR Mendelsohn","year":"2018","unstructured":"Mendelsohn AR, Larrick JW. Cellular senescence as the key intermediate in Tau-Mediated neurodegeneration. Rejuvenation Res. 2018;21:572\u20139.","journal-title":"Rejuvenation Res"},{"key":"4285_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fnagi.2017.00194","volume":"9","author":"B Spittau","year":"2017","unstructured":"Spittau B. Aging Microglia-Phenotypes, functions and implications for Age-Related neurodegenerative diseases. Front Aging Neurosci. 2017;9:194.","journal-title":"Front Aging Neurosci"},{"key":"4285_CR17","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1016\/j.neuron.2024.07.016","volume":"112","author":"YM Kattimani","year":"2024","unstructured":"Kattimani YM, Waisman A. Microglia\u2019s heroic battle against neurodegeneration. Neuron. 2024;112:2661\u20133.","journal-title":"Neuron"},{"key":"4285_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cobme.2017.11.002","volume":"5","author":"BD Gastfriend","year":"2018","unstructured":"Gastfriend BD, Palecek SP, Shusta EV. Modeling the blood-brain barrier: beyond the endothelial cells. Curr Opin Biomed Eng. 2018;5:6\u201312.","journal-title":"Curr Opin Biomed Eng"},{"key":"4285_CR19","doi-asserted-by":"publisher","unstructured":"Kim D, Yoo SH, Yeon GB, Oh SS, Shin WH, Kang HC, Lee CK, Kim HW, Kim DS. Senescent astrocytes derived from human pluripotent stem cells reveal Age-Related changes and implications for neurodegeneration. Aging Dis. 2024. Epub ahead of print. https:\/\/doi.org\/10.14336\/AD.2024.0089","DOI":"10.14336\/AD.2024.0089"},{"key":"4285_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnagi.2020.00148","volume":"12","author":"X Han","year":"2020","unstructured":"Han X, Zhang T, Liu H, Mi Y, Gou X. Astrocyte senescence and Alzheimer\u2019s disease: A review. Front Aging Neurosci. 2020;12:148.","journal-title":"Front Aging Neurosci"},{"key":"4285_CR21","doi-asserted-by":"publisher","first-page":"e13521","DOI":"10.1111\/acel.13521","volume":"21","author":"I Matias","year":"2022","unstructured":"Matias I, Diniz LP, Damico IV, Araujo APB, Neves LDS, Vargas G, Leite REP, Suemoto CK, Nitrini R, Jacob-Filho W, Grinberg LT, Hol EM, Middeldorp J, Gomes FCA. Loss of lamin-B1 and defective nuclear morphology are hallmarks of astrocyte senescence in vitro and in the aging human hippocampus. Aging Cell. 2022;21:e13521.","journal-title":"Aging Cell"},{"key":"4285_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnagi.2016.00208","volume":"8","author":"EP Crowe","year":"2016","unstructured":"Crowe EP, Tuzer F, Gregory BD, Donahue G, Gosai SJ, Cohen J, Leung YY, Yetkin E, Nativio R, Wang LS, Sell C, Bonini NM, Berger SL. Johnson FB and Torres C. Changes in the transcriptome of human astrocytes accompanying oxidative Stress-Induced senescence. Front Aging Neurosci. 2016;8:208.","journal-title":"Front Aging Neurosci"},{"key":"4285_CR23","doi-asserted-by":"publisher","first-page":"113466","DOI":"10.1016\/j.expneurol.2020.113466","volume":"334","author":"K Simmnacher","year":"2020","unstructured":"Simmnacher K, Krach F, Schneider Y, Alecu JE, Mautner L, Klein P, Roybon L, Prots I, Xiang W, Winner B. Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020;334:113466.","journal-title":"Exp Neurol"},{"key":"4285_CR24","doi-asserted-by":"publisher","first-page":"e12937","DOI":"10.1111\/acel.12937","volume":"18","author":"J Cohen","year":"2019","unstructured":"Cohen J, Torres C. Astrocyte senescence: evidence and significance. Aging Cell. 2019;18:e12937.","journal-title":"Aging Cell"},{"key":"4285_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11033-024-09297-9","volume":"51","author":"X Wang","year":"2024","unstructured":"Wang X, Deng Y, Xiao Y, Wang F, Tang Z, Qi X. A double inducible cell ablation system for eliminating senescent astrocytes via apoptosis. Mol Biol Rep. 2024;51:363.","journal-title":"Mol Biol Rep"},{"key":"4285_CR26","doi-asserted-by":"crossref","unstructured":"Rivellini C, Porrello E, Dina G, Mrakic-Sposta S, Vezzoli A, Bacigaluppi M, Gullotta GS, Chaabane L, Leocani L, Marenna S, Colombo E, Farina C, Newcombe J, Nave KA, Pardi R. Quattrini A and previtali SC. JAB1 deletion in oligodendrocytes causes senescence-induced inflammation and neurodegeneration in mice. J Clin Invest. 2022;132.","DOI":"10.1172\/JCI145071"},{"key":"4285_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010;68:409\u201327.","journal-title":"Neuron"},{"key":"4285_CR28","first-page":"151","volume":"72","author":"F Shimizu","year":"2020","unstructured":"Shimizu F, Kanda T. [Pericytes of the nervous system: physiological and pathological role]. Brain Nerve. 2020;72:151\u20138.","journal-title":"Brain Nerve"},{"key":"4285_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2023.01.037","volume":"645","author":"T Iwao","year":"2023","unstructured":"Iwao T, Takata F, Matsumoto J, Goto Y, Aridome H, Yasunaga M, Yokoya M, Kataoka Y, Dohgu S. Senescence in brain pericytes attenuates blood-brain barrier function in vitro: A comparison of serially passaged and isolated pericytes from aged rat brains. Biochem Biophys Res Commun. 2023;645:154\u201363.","journal-title":"Biochem Biophys Res Commun"},{"key":"4285_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bpa.12152","volume":"24","author":"EA Winkler","year":"2014","unstructured":"Winkler EA, Sagare AP, Zlokovic BV. The pericyte: a forgotten cell type with important implications for Alzheimer\u2019s disease? Brain Pathol. 2014;24:371\u201386.","journal-title":"Brain Pathol"},{"key":"4285_CR31","doi-asserted-by":"publisher","unstructured":"Li R, Li Y, Zuo H, Pei G, Huang S, Hou Y. Alzheimer\u2019s Amyloid-\u03b2 Accelerates Cell Senescence and Suppresses SIRT1 in Human Neural Stem Cells. Biomolecules. 2024;14(2):189. https:\/\/doi.org\/10.3390\/biom14020189","DOI":"10.3390\/biom14020189"},{"key":"4285_CR32","doi-asserted-by":"crossref","unstructured":"Li Y, Sun J, Zheng Y, Xu T, Zhang Y, Wang Y. MiR-302-Induced anti-aging neural stem cells enhance cognitive function and extend lifespan. BioRxiv. 2023:2023.02.13.528232.","DOI":"10.1101\/2023.02.13.528232"},{"key":"4285_CR33","doi-asserted-by":"crossref","unstructured":"Yamakuchi M, Hashiguchi T. Endothelial cell aging: how MiRNAs contribute?? J Clin Med. 2018;7.","DOI":"10.3390\/jcm7070170"},{"key":"4285_CR34","first-page":"764","volume":"18","author":"PF Wong","year":"2019","unstructured":"Wong PF, Tong KL, Jamal J, Khor ES, Lai SL, Mustafa MR. Senescent HUVECs-secreted exosomes trigger endothelial barrier dysfunction in young endothelial cells. Excli J. 2019;18:764\u201376.","journal-title":"Excli J"},{"key":"4285_CR35","doi-asserted-by":"publisher","first-page":"183061","DOI":"10.1016\/j.bbamem.2019.183061","volume":"1861","author":"T Kulkarni","year":"2019","unstructured":"Kulkarni T, Angom RS, Das P, Bhattacharya S, Mukhopadhyay D. Nanomechanical insights: amyloid beta oligomer-induced senescent brain endothelial cells. Biochim Biophys Acta Biomembr. 2019;1861:183061.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4285_CR36","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1096\/fj.00-0723fje","volume":"15","author":"JS Park","year":"2001","unstructured":"Park JS, Park WY, Cho KA, Kim DI, Jhun BH, Kim SR, Park SC. Down-regulation of amphiphysin-1 is responsible for reduced receptor-mediated endocytosis in the senescent cells. Faseb J. 2001;15:1625\u20137.","journal-title":"Faseb J"},{"key":"4285_CR37","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Esp\u00edn D, Rovira M, Galiana I, Gim\u00e9nez C, Lozano-Torres B, Paez-Ribes M, Llanos S, Chaib S, Mu\u00f1oz-Mart\u00edn M, Ucero AC, Garaulet G, Mulero F, Dann SG, VanArsdale T, Shields DJ, Bernardos A, Murgu\u00eda JR. Mart\u00ednez-M\u00e1\u00f1ez R and Serrano M. A versatile drug delivery system targeting senescent cells. EMBO Mol Med. 2018;10.","DOI":"10.15252\/emmm.201809355"},{"key":"4285_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2016.06.002","volume":"111","author":"DJ Wagner","year":"2016","unstructured":"Wagner DJ, Hu T, Wang J. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. Pharmacol Res. 2016;111:237\u201346.","journal-title":"Pharmacol Res"},{"key":"4285_CR39","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1248\/bpb.b22-00322","volume":"45","author":"A Sanagawa","year":"2022","unstructured":"Sanagawa A, Hotta Y, Sezaki R, Tomita N, Kataoka T, Furukawa-Hibi Y, Kimura K. Effect of replicative senescence on the expression and function of transporters in human proximal renal tubular epithelial cells. Biol Pharm Bull. 2022;45:1636\u201343.","journal-title":"Biol Pharm Bull"},{"key":"4285_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bcp.2006.10.010","volume":"73","author":"T Terada","year":"2007","unstructured":"Terada T, Inui K. Gene expression and regulation of drug transporters in the intestine and kidney. Biochem Pharmacol. 2007;73:440\u20139.","journal-title":"Biochem Pharmacol"},{"key":"4285_CR41","first-page":"821","volume":"42","author":"C Kang","year":"2019","unstructured":"Kang C. Senolytics and senostatics: A Two-Pronged approach to target cellular senescence for delaying aging and Age-Related diseases. Mol Cells. 2019;42:821\u20137.","journal-title":"Mol Cells"},{"key":"4285_CR42","doi-asserted-by":"crossref","unstructured":"Ruscetti M. Abstract SoA2-01: cellular senescence: the senescence-associated secretory phenotype (SASP) and immunity. Cancer Res. 2024;84:SoA2-01-SoA2-01.","DOI":"10.1158\/1538-7445.SABCS23-SoA2-01"},{"key":"4285_CR43","doi-asserted-by":"crossref","unstructured":"Benveniste EN, Cytokines. Encyclopedia of the Neurological Sciences. 2014:921\u2013925.","DOI":"10.1016\/B978-0-12-385157-4.00175-5"},{"key":"4285_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pharmthera.2011.12.002","volume":"134","author":"HO Tayeb","year":"2012","unstructured":"Tayeb HO, Yang HD, Price BH, Tarazi FI. Pharmacotherapies for Alzheimer\u2019s disease: beyond cholinesterase inhibitors. Pharmacol Ther. 2012;134:8\u201325.","journal-title":"Pharmacol Ther"},{"key":"4285_CR45","doi-asserted-by":"crossref","unstructured":"Lushchak O, Schosserer M, Grillari J. Senopathies-Diseases associated with cellular senescence. Biomolecules. 2023;13.","DOI":"10.3390\/biom13060966"},{"key":"4285_CR46","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cmet.2024.03.009","volume":"36","author":"W Tao","year":"2024","unstructured":"Tao W, Yu Z, Han JJ. Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators. Cell Metab. 2024;36:1126\u2013e11435.","journal-title":"Cell Metab"},{"key":"4285_CR47","first-page":"118","volume":"155","author":"V Silani","year":"2017","unstructured":"Silani V. Therapy in amyotrophic lateral sclerosis (ALS): an unexpected evolving scenario. Arch Ital Biol. 2017;155:118\u201330.","journal-title":"Arch Ital Biol"},{"key":"4285_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539:180\u20136.","journal-title":"Nature"},{"key":"4285_CR49","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1038\/s44318-024-00148-8","volume":"43","author":"S Zocher","year":"2024","unstructured":"Zocher S. Targeting neuronal epigenomes for brain rejuvenation. Embo J. 2024;43:3312\u201326.","journal-title":"Embo J"},{"key":"4285_CR50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41392-023-01343-5","volume":"8","author":"S Ji","year":"2023","unstructured":"Ji S, Xiong M, Chen H, Liu Y, Zhou L, Hong Y, Wang M, Wang C, Fu X, Sun X. Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. Signal Transduct Target Ther. 2023;8:116.","journal-title":"Signal Transduct Target Ther"},{"key":"4285_CR51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10:68.","journal-title":"Stem Cell Res Ther"},{"key":"4285_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/197452a0","volume":"197","author":"AJ Becker","year":"1963","unstructured":"Becker AJ, Mc CE, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963;197:452\u20134.","journal-title":"Nature"},{"key":"4285_CR53","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1007\/s00018-019-03199-x","volume":"76","author":"X Wang","year":"2019","unstructured":"Wang X. Stem cells in tissues, organoids, and cancers. Cell Mol Life Sci. 2019;76:4043\u201370.","journal-title":"Cell Mol Life Sci"},{"key":"4285_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000345615","volume":"85","author":"G Kolios","year":"2013","unstructured":"Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013;85:3\u201310.","journal-title":"Respiration"},{"key":"4285_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/15384101.2015.1120925","volume":"15","author":"S Ruijtenberg","year":"2016","unstructured":"Ruijtenberg S, van den Heuvel S. Coordinating cell proliferation and differentiation: antagonism between cell cycle regulators and cell type-specific gene expression. Cell Cycle. 2016;15:196\u2013212.","journal-title":"Cell Cycle"},{"key":"4285_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stem.2019.07.002","volume":"25","author":"Y Post","year":"2019","unstructured":"Post Y, Clevers H. Defining adult stem cell function at its simplest: the ability to replace lost cells through mitosis. Cell Stem Cell. 2019;25:174\u201383.","journal-title":"Cell Stem Cell"},{"key":"4285_CR57","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.4252\/wjsc.v13.i11.1714","volume":"13","author":"A Picerno","year":"2021","unstructured":"Picerno A, Stasi A, Franzin R, Curci C, di Bari I, Gesualdo L, Sallustio F. Why stem\/progenitor cells lose their regenerative potential. World J Stem Cells. 2021;13:1714\u201332.","journal-title":"World J Stem Cells"},{"key":"4285_CR58","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7:272.","journal-title":"Signal Transduct Target Ther"},{"key":"4285_CR59","doi-asserted-by":"crossref","unstructured":"Bonaventura G, Munaf\u00f2 A, Bellanca CM, La Cognata V, Iemmolo R, Attaguile GA, Di Mauro R, Di Benedetto G, Cantarella G, Barcellona ML, Cavallaro S, Bernardini R. Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? Cells. 2021;10.","DOI":"10.3390\/cells10081992"},{"key":"4285_CR60","doi-asserted-by":"crossref","unstructured":"Sivandzade F, Cucullo L. Regenerative stem cell therapy for neurodegenerative diseases: an overview. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22042153"},{"key":"4285_CR61","doi-asserted-by":"publisher","unstructured":"Ford E, Pearlman J, Ruan T, Manion J, Waller M, Neely GG, Caron L. Human pluripotent stem Cells-Based therapies for neurodegenerative diseases: current status and challenges. Cells. 2020;9(11):2517. https:\/\/doi.org\/10.3390\/cells9112517","DOI":"10.3390\/cells9112517"},{"key":"4285_CR62","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145\u20137.","journal-title":"Science"},{"key":"4285_CR63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"4285_CR64","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"4285_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-022-04593-5","volume":"605","author":"J Guan","year":"2022","unstructured":"Guan J, Wang G, Wang J, Zhang Z, Fu Y, Cheng L, Meng G, Lyu Y, Zhu J, Li Y, Wang Y, Liuyang S, Liu B, Yang Z, He H, Zhong X, Chen Q, Zhang X, Sun S, Lai W, Shi Y, Liu L, Wang L, Li C, Lu S, Deng H. Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature. 2022;605:325\u201331.","journal-title":"Nature"},{"key":"4285_CR66","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1126\/science.1239278","volume":"341","author":"P Hou","year":"2013","unstructured":"Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341:651\u20134.","journal-title":"Science"},{"key":"4285_CR67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41536-022-00221-y","volume":"7","author":"BM Hiller","year":"2022","unstructured":"Hiller BM, Marmion DJ, Thompson CA, Elliott NA, Federoff H, Brundin P, Mattis VB, McMahon CW, Kordower JH. Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson\u2019s disease. NPJ Regen Med. 2022;7:24.","journal-title":"NPJ Regen Med"},{"key":"4285_CR68","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1038\/s41467-022-30777-8","volume":"13","author":"Z Alekseenko","year":"2022","unstructured":"Alekseenko Z, Dias JM, Adler AF, Kozhevnikova M, van Lunteren JA, Nolbrant S, Jeggari A, Vasylovska S, Yoshitake T, Kehr J, Carl\u00e9n M, Alexeyenko A, Parmar M, Ericson J. Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery. Nat Commun. 2022;13:3046.","journal-title":"Nat Commun"},{"key":"4285_CR69","doi-asserted-by":"publisher","first-page":"1202027","DOI":"10.3389\/fnins.2023.1202027","volume":"17","author":"R Nakamura","year":"2023","unstructured":"Nakamura R, Nonaka R, Oyama G, Jo T, Kamo H, Nuermaimaiti M, Akamatsu W, Ishikawa KI, Hattori N. A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson\u2019s disease. Front Neurosci. 2023;17:1202027.","journal-title":"Front Neurosci"},{"key":"4285_CR70","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fbioe.2019.00400","volume":"7","author":"YJ Hong","year":"2019","unstructured":"Hong YJ, Do JT. Neural lineage differentiation from pluripotent stem cells to mimic human brain tissues. Front Bioeng Biotechnol. 2019;7:400.","journal-title":"Front Bioeng Biotechnol"},{"key":"4285_CR71","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/stem.626","volume":"29","author":"CJ Bissonnette","year":"2011","unstructured":"Bissonnette CJ, Lyass L, Bhattacharyya BJ, Belmadani A, Miller RJ, Kessler JA. The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells. 2011;29:802\u201311.","journal-title":"Stem Cells"},{"key":"4285_CR72","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nn.4273","volume":"19","author":"S Sances","year":"2016","unstructured":"Sances S, Bruijn LI, Chandran S, Eggan K, Ho R, Klim JR, Livesey MR, Lowry E, Macklis JD, Rushton D, Sadegh C, Sareen D, Wichterle H, Zhang SC, Svendsen CN. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat Neurosci. 2016;19:542\u201353.","journal-title":"Nat Neurosci"},{"key":"4285_CR73","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.neuron.2023.01.010","volume":"111","author":"MJ Workman","year":"2023","unstructured":"Workman MJ, Lim RG, Wu J, Frank A, Ornelas L, Panther L, Galvez E, Perez D, Meepe I, Lei S, Valencia V, Gomez E, Liu C, Moran R, Pinedo L, Tsitkov S, Ho R, Kaye JA, Thompson T, Rothstein JD, Finkbeiner S, Fraenkel E, Sareen D, Thompson LM, Svendsen CN. Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects. Neuron. 2023;111:1191\u2013e12045.","journal-title":"Neuron"},{"key":"4285_CR74","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-Based cell Therapy-Promise and challenges. Cell Stem Cell. 2020;27:523\u201331.","journal-title":"Cell Stem Cell"},{"key":"4285_CR75","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z, Carrillo-Reid L, Auyeung G, Antonacci C, Buch A, Yang L, Beal MF, Surmeier DJ, Kordower JH, Tabar V, Studer L. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature. 2011;480:547\u201351.","journal-title":"Nature"},{"key":"4285_CR76","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, Mizuma H, Takara S, Takahashi R, Inoue H, Morita S, Yamamoto M, Okita K, Nakagawa M, Parmar M, Takahashi J. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature. 2017;548:592\u20136.","journal-title":"Nature"},{"key":"4285_CR77","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.7150\/thno.80271","volume":"13","author":"X Zheng","year":"2023","unstructured":"Zheng X, Han D, Liu W, Wang X, Pan N, Wang Y, Chen Z. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson\u2019s disease. Theranostics. 2023;13:2673\u201392.","journal-title":"Theranostics"},{"key":"4285_CR78","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","volume":"15","author":"S Grealish","year":"2014","unstructured":"Grealish S, Diguet E, Kirkeby A, Mattsson B, Heuer A, Bramoulle Y, Van Camp N, Perrier AL, Hantraye P, Bj\u00f6rklund A, Parmar M. Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease. Cell Stem Cell. 2014;15:653\u201365.","journal-title":"Cell Stem Cell"},{"key":"4285_CR79","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi D, Magotani H, Kikuchi T, Ikeda M, Hiramatsu S, Yoshida K, Amano N, Nomura M, Umekage M, Morizane A, Takahashi J. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat Commun. 2020;11:3369.","journal-title":"Nat Commun"},{"key":"4285_CR80","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.stem.2023.05.015","volume":"30","author":"MS Kim","year":"2023","unstructured":"Kim MS, Ra EA, Kweon SH, Seo BA, Ko HS, Oh Y, Lee G. Advanced human iPSC-based preclinical model for Parkinson\u2019s disease with optogenetic alpha-synuclein aggregation. Cell Stem Cell. 2023;30:973\u2013e98611.","journal-title":"Cell Stem Cell"},{"key":"4285_CR81","doi-asserted-by":"publisher","first-page":"e00436","DOI":"10.1016\/j.neurot.2024.e00436","volume":"21","author":"N Prudon","year":"2024","unstructured":"Prudon N, Cordero-Espinoza L, Abarkan M, Gurchenkov B, Morel C, Lepleux M, De Luca V, Lartigue M, Cabanas H, Pujol N, Milvoy L, Morand P, Moncaubeig F, Wurtz H, Poin\u00e7ot L, De Marco M, Jonckeau A, Pletenka J, Luquet E, Sovera A, Hardo\u00fcin J, Neves IJ, Machado-Hitau A, Schmit K, Piouceau L, Guilbert S, Manache-Alberici L, Lanero Fidalgo M, Dab\u00e9e G, Dufourd T, Schroeder J, Alessandri K, Bezard E, Faggiani E, Feyeux M. Bioreactor-produced iPSCs-derived dopaminergic neuron-containing neural microtissues innervate and normalize rotational bias in a dose-dependent manner in a Parkinson rat model. Neurotherapeutics. 2024;21:e00436.","journal-title":"Neurotherapeutics"},{"key":"4285_CR82","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/JCI130767","volume":"130","author":"B Song","year":"2020","unstructured":"Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, Bolshakov VY, Kong SW. Schweitzer JS and Kim KS. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson\u2019s disease models. J Clin Invest. 2020;130:904\u201320.","journal-title":"J Clin Invest"},{"key":"4285_CR83","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1172\/JCI134031","volume":"130","author":"J Takahashi","year":"2020","unstructured":"Takahashi J. Preclinical evaluation of patient-derived cells shows promise for Parkinson\u2019s disease. J Clin Invest. 2020;130:601\u20133.","journal-title":"J Clin Invest"},{"key":"4285_CR84","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"J Piao","year":"2021","unstructured":"Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, Rosen S, Ramnarine K, Horn C, Fredrickson C, Wong K, Safford B, Kriks S, El Maarouf A, Rutishauser U, Henchcliffe C, Wang Y, Riviere I, Mann S, Bermudez V, Irion S, Studer L. Tomishima M and Tabar V. Preclinical efficacy and safety of a human embryonic stem Cell-Derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell. 2021;28:217\u2013e2297.","journal-title":"Cell Stem Cell"},{"key":"4285_CR85","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","volume":"30","author":"A Kirkeby","year":"2023","unstructured":"Kirkeby A, Nelander J, Hoban DB, Rogelius N, Bjartmarz H, Storm P, Fiorenzano A, Adler AF, Vale S, Mudannayake J, Zhang Y, Cardoso T, Mattsson B, Landau AM, Glud AN, S\u00f8rensen JC, Lillethorup TP, Lowdell M, Carvalho C, Bain O, van Vliet T, Lindvall O, Bj\u00f6rklund A, Harry B, Cutting E, Widner H, Paul G, Barker RA, Parmar M. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson\u2019s disease, STEM-PD. Cell Stem Cell. 2023;30:1299\u2013e13149.","journal-title":"Cell Stem Cell"},{"key":"4285_CR86","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/bs.pbr.2016.11.004","volume":"230","author":"J Takahashi","year":"2017","unstructured":"Takahashi J. Strategies for bringing stem cell-derived dopamine neurons to the clinic: the Kyoto trial. Prog Brain Res. 2017;230:213\u201326.","journal-title":"Prog Brain Res"},{"key":"4285_CR87","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","volume":"21","author":"RA Barker","year":"2017","unstructured":"Barker RA, Parmar M, Studer L, Takahashi J. Human trials of stem Cell-Derived dopamine neurons for Parkinson\u2019s disease: dawn of a new era. Cell Stem Cell. 2017;21:569\u201373.","journal-title":"Cell Stem Cell"},{"key":"4285_CR88","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P. Carter BS and Kim KS. Personalized iPSC-Derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl J Med. 2020;382:1926\u201332.","journal-title":"N Engl J Med"},{"key":"4285_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","volume":"31","author":"S Park","year":"2024","unstructured":"Park S, Park CW, Eom JH, Jo MY, Hur HJ, Choi SK, Lee JS, Nam ST, Jo KS, Oh YW, Lee J, Kim S, Kim DH, Park CY, Kim SJ, Lee HY, Cho MS, Kim DS, Kim DW. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson\u2019s disease. Cell Stem Cell. 2024;31:25\u2013e388.","journal-title":"Cell Stem Cell"},{"key":"4285_CR90","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/stmcls\/sxae042","volume":"42","author":"BJ Clark","year":"2024","unstructured":"Clark BJ, Lelos MJ, Loring JF. Advancing Parkinson\u2019s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells. Stem Cells. 2024;42:781\u201390.","journal-title":"Stem Cells"},{"key":"4285_CR91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-016-0106-3","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, Li S, He XB, Cheng C, Le W. Induced pluripotent stem cells in Alzheimer\u2019s disease: applications for disease modeling and cell-replacement therapy. Mol Neurodegener. 2016;11:39.","journal-title":"Mol Neurodegener"},{"key":"4285_CR92","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.neuron.2017.02.001","volume":"93","author":"I Espuny-Camacho","year":"2017","unstructured":"Espuny-Camacho I, Arranz AM, Fiers M, Snellinx A, Ando K, Munck S, Bonnefont J, Lambot L, Corthout N, Omodho L, Vanden Eynden E, Radaelli E, Tesseur I, Wray S, Ebneth A, Hardy J, Leroy K, Brion JP, Vanderhaeghen P, De Strooper B. Hallmarks of Alzheimer\u2019s disease in Stem-Cell-Derived human neurons transplanted into mouse brain. Neuron. 2017;93:1066\u2013e10818.","journal-title":"Neuron"},{"key":"4285_CR93","first-page":"1172","volume":"21","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Zhang N, Hu N, Jiang R, Lu H, Xuan A, Long D, Chen Y. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein\/presenilin 1 Transgenic mouse model of Alzheimer\u2019s disease. Mol Med Rep. 2020;21:1172\u201380.","journal-title":"Mol Med Rep"},{"key":"4285_CR94","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","volume":"25","author":"J Penney","year":"2020","unstructured":"Penney J, Ralvenius WT, Tsai LH. Modeling Alzheimer\u2019s disease with iPSC-derived brain cells. Mol Psychiatry. 2020;25:148\u201367.","journal-title":"Mol Psychiatry"},{"key":"4285_CR95","doi-asserted-by":"publisher","first-page":"101655","DOI":"10.1016\/j.arr.2022.101655","volume":"80","author":"ZB Wang","year":"2022","unstructured":"Wang ZB, Wang ZT, Sun Y, Tan L, Yu JT. The future of stem cell therapies of Alzheimer\u2019s disease. Ageing Res Rev. 2022;80:101655.","journal-title":"Ageing Res Rev"},{"key":"4285_CR96","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N. Modeling Familial Alzheimer\u2019s disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20:4530\u20139.","journal-title":"Hum Mol Genet"},{"key":"4285_CR97","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, Carson CT, Laurent LC, Marsala M, Gage FH, Remes AM, Koo EH, Goldstein LS. Probing sporadic and Familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature. 2012;482:216\u201320.","journal-title":"Nature"},{"key":"4285_CR98","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neulet.2013.10.043","volume":"557 Pt B","author":"N Fujiwara","year":"2013","unstructured":"Fujiwara N, Shimizu J, Takai K, Arimitsu N, Saito A, Kono T, Umehara T, Ueda Y, Wakisaka S, Suzuki T, Suzuki N. Restoration of Spatial memory dysfunction of human APP Transgenic mice by transplantation of neuronal precursors derived from human iPS cells. Neurosci Lett. 2013;557 Pt B:129\u201334.","journal-title":"Neurosci Lett"},{"key":"4285_CR99","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/jmcb\/mjaa027","volume":"12","author":"R Tao","year":"2020","unstructured":"Tao R, Lu R, Wang J, Zeng S, Zhang T, Guo W, Zhang X, Cheng Q, Yue C, Wang Y, Jing N. Probing the therapeutic potential of TRPC6 for Alzheimer\u2019s disease in live neurons from patient-specific iPSCs. J Mol Cell Biol. 2020;12:807\u201316.","journal-title":"J Mol Cell Biol"},{"key":"4285_CR100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13619-024-00204-y","volume":"13","author":"R Tao","year":"2024","unstructured":"Tao R, Yue C, Guo Z, Guo W, Yao Y, Yang X, Shao Z, Gao C, Ding J, Shen L, Chen S, Jing N. Subtype-specific neurons from patient iPSCs display distinct neuropathological features of Alzheimer\u2019s disease. Cell Regen. 2024;13:21.","journal-title":"Cell Regen"},{"key":"4285_CR101","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.mcn.2013.07.007","volume":"56","author":"MF Burkhardt","year":"2013","unstructured":"Burkhardt MF, Martinez FJ, Wright S, Ramos C, Volfson D, Mason M, Garnes J, Dang V, Lievers J, Shoukat-Mumtaz U, Martinez R, Gai H, Blake R, Vaisberg E, Grskovic M, Johnson C, Irion S, Bright J, Cooper B, Nguyen L. Griswold-Prenner I and Javaherian A. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci. 2013;56:355\u201364.","journal-title":"Mol Cell Neurosci"},{"key":"4285_CR102","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1177\/0963689718785154","volume":"27","author":"JH Lee","year":"2018","unstructured":"Lee JH, Liu JW, Lin SZ, Harn HJ, Chiou TW. Advances in Patient-Specific induced pluripotent stem cells shed light on drug discovery for amyotrophic lateral sclerosis. Cell Transpl. 2018;27:1301\u201312.","journal-title":"Cell Transpl"},{"key":"4285_CR103","doi-asserted-by":"publisher","first-page":"104680","DOI":"10.1016\/j.nbd.2019.104680","volume":"134","author":"J Hawrot","year":"2020","unstructured":"Hawrot J, Imhof S, Wainger BJ. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol Dis. 2020;134:104680.","journal-title":"Neurobiol Dis"},{"key":"4285_CR104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2021.12.008","volume":"29","author":"E Giacomelli","year":"2022","unstructured":"Giacomelli E, Vahsen BF, Calder EL, Xu Y, Scaber J, Gray E, Dafinca R, Talbot K, Studer L. Human stem cell models of neurodegeneration: from basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell. 2022;29:11\u201335.","journal-title":"Cell Stem Cell"},{"key":"4285_CR105","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","volume":"3","author":"T Kondo","year":"2014","unstructured":"Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M, Takahashi R, Okano H, Yamanaka S, Inoue H. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Rep. 2014;3:242\u20139.","journal-title":"Stem Cell Rep"},{"key":"4285_CR106","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/hmg\/ddt425","volume":"23","author":"M Nizzardo","year":"2014","unstructured":"Nizzardo M, Simone C, Rizzo F, Ruggieri M, Salani S, Riboldi G, Faravelli I, Zanetta C, Bresolin N, Comi GP, Corti S. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4\u2009+\u2009neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum Mol Genet. 2014;23:342\u201354.","journal-title":"Hum Mol Genet"},{"key":"4285_CR107","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5966\/sctm.2012-0042","volume":"2","author":"IR Popescu","year":"2013","unstructured":"Popescu IR, Nicaise C, Liu S, Bisch G, Knippenberg S, Daubie V, Bohl D, Pochet R. Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis. Stem Cells Transl Med. 2013;2:167\u201374.","journal-title":"Stem Cells Transl Med"},{"key":"4285_CR108","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.4103\/1673-5374.332123","volume":"17","author":"B Liu","year":"2022","unstructured":"Liu B, Li M, Zhang L, Chen Z, Lu P. Motor neuron replacement therapy for amyotrophic lateral sclerosis. Neural Regen Res. 2022;17:1633\u20139.","journal-title":"Neural Regen Res"},{"key":"4285_CR109","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jgg.2015.10.001","volume":"42","author":"J Brix","year":"2015","unstructured":"Brix J, Zhou Y, Luo Y. The epigenetic reprogramming roadmap in generation of iPSCs from somatic cells. J Genet Genomics. 2015;42:661\u201370.","journal-title":"J Genet Genomics"},{"key":"4285_CR110","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jcyt.2019.10.001","volume":"21","author":"Y Sato","year":"2019","unstructured":"Sato Y, Bando H, Di Piazza M, Gowing G, Herberts C, Jackman S, Leoni G, Libertini S, MacLachlan T, McBlane JW, Pereira Mouri\u00e8s L, Sharpe M, Shingleton W, Surmacz-Cordle B, Yamamoto K, van der Laan JW. Tumorigenicity assessment of cell therapy products: the need for global consensus and points to consider. Cytotherapy. 2019;21:1095\u2013111.","journal-title":"Cytotherapy"},{"key":"4285_CR111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13287-023-03308-5","volume":"14","author":"ME Bogomiakova","year":"2023","unstructured":"Bogomiakova ME, Sekretova EK, Anufrieva KS, Khabarova PO, Kazakova AN, Bobrovsky PA, Grigoryeva TV, Eremeev AV, Lebedeva OS, Bogomazova AN, Lagarkova MA. iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors. Stem Cell Res Ther. 2023;14:77.","journal-title":"Stem Cell Res Ther"},{"key":"4285_CR112","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","volume":"4","author":"S Petrus-Reurer","year":"2021","unstructured":"Petrus-Reurer S, Romano M, Howlett S, Jones JL, Lombardi G, Saeb-Parsy K. Immunological considerations and challenges for regenerative cellular therapies. Commun Biol. 2021;4:798.","journal-title":"Commun Biol"},{"key":"4285_CR113","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.stemcr.2018.12.015","volume":"12","author":"H Jin","year":"2019","unstructured":"Jin H, Zhang YT, Yang Y, Wen LY, Wang JH, Xu HY, Lai BQ, Feng B, Che MT, Qiu XC, Li ZL, Wang LJ, Ruan JW, Jiang B, Zeng X, Deng QW, Li G, Ding Y, Zeng YS. Electroacupuncture facilitates the integration of neural stem Cell-Derived neural network with transected rat spinal cord. Stem Cell Rep. 2019;12:274\u201389.","journal-title":"Stem Cell Rep"},{"key":"4285_CR114","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s13287-023-03597-w","volume":"14","author":"N Patil","year":"2023","unstructured":"Patil N, Korenfeld O, Scalf RN, Lavoie N, Huntemer-Silveira A, Han G, Swenson R, Parr AM. Electrical stimulation affects the differentiation of transplanted regionally specific human spinal neural progenitor cells (sNPCs) after chronic spinal cord injury. Stem Cell Res Ther. 2023;14:378.","journal-title":"Stem Cell Res Ther"},{"key":"4285_CR115","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L da Silva Meirelles","year":"2006","unstructured":"da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204\u201313.","journal-title":"J Cell Sci"},{"key":"4285_CR116","first-page":"393","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393\u2013403.","journal-title":"Cell Tissue Kinet"},{"key":"4285_CR117","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biochi.2004.11.007","volume":"87","author":"AM Rodriguez","year":"2005","unstructured":"Rodriguez AM, Elabd C, Amri EZ, Ailhaud G, Dani C. The human adipose tissue is a source of multipotent stem cells. Biochimie. 2005;87:125\u20138.","journal-title":"Biochimie"},{"key":"4285_CR118","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/jcb.23042","volume":"112","author":"X Zhang","year":"2011","unstructured":"Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, Igura K, Satoh H, Yokomi I, Nishimura T, Yamaguchi S, Yoshimura K, Rubinstein P, Takahashi TA. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem. 2011;112:1206\u201318.","journal-title":"J Cell Biochem"},{"key":"4285_CR119","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/sctm.17-0129","volume":"6","author":"RM Samsonraj","year":"2017","unstructured":"Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 2017;6:2173\u201385.","journal-title":"Stem Cells Transl Med"},{"key":"4285_CR120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00441-018-02980-x","volume":"376","author":"A Aliaghaei","year":"2019","unstructured":"Aliaghaei A, Boroujeni ME, Ahmadi H, Bayat AH, Tavirani MR, Abdollahifar MA, Pooyafar MH, Mansouri V. Dental pulp stem cell transplantation ameliorates motor function and prevents cerebellar atrophy in rat model of cerebellar ataxia. Cell Tissue Res. 2019;376:179\u201387.","journal-title":"Cell Tissue Res"},{"key":"4285_CR121","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0076-6879(06)20016-8","volume":"420","author":"NW Marion","year":"2006","unstructured":"Marion NW, Mao JJ. Mesenchymal stem cells and tissue engineering. Methods Enzymol. 2006;420:339\u201361.","journal-title":"Methods Enzymol"},{"key":"4285_CR122","doi-asserted-by":"crossref","unstructured":"Fraile M, Eiro N, Costa LA, Mart\u00edn A, Vizoso FJ. Aging and mesenchymal stem cells: basic concepts, challenges and strategies. Biology (Basel). 2022;11.","DOI":"10.3390\/biology11111678"},{"key":"4285_CR123","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.7150\/thno.46436","volume":"11","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Ge J, Huang C, Liu H, Jiang H. Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics. Theranostics. 2021;11:5675\u201385.","journal-title":"Theranostics"},{"key":"4285_CR124","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","volume":"262","author":"K Le Blanc","year":"2007","unstructured":"Le Blanc K, Ringd\u00e9n O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262:509\u201325.","journal-title":"J Intern Med"},{"key":"4285_CR125","doi-asserted-by":"publisher","first-page":"15731","DOI":"10.1038\/s41598-023-42485-4","volume":"13","author":"MI Khan","year":"2023","unstructured":"Khan MI, Jeong ES, Khan MZ, Shin JH, Kim JD. Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer\u2019s pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways. Sci Rep. 2023;13:15731.","journal-title":"Sci Rep"},{"key":"4285_CR126","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1002\/jcp.26192","volume":"233","author":"D Lo Furno","year":"2018","unstructured":"Lo Furno D, Mannino G, Giuffrida R. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. J Cell Physiol. 2018;233:3982\u201399.","journal-title":"J Cell Physiol"},{"key":"4285_CR127","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13287-017-0567-5","volume":"8","author":"T Duncan","year":"2017","unstructured":"Duncan T, Valenzuela M. Alzheimer\u2019s disease, dementia, and stem cell therapy. Stem Cell Res Ther. 2017;8:111.","journal-title":"Stem Cell Res Ther"},{"key":"4285_CR128","doi-asserted-by":"publisher","first-page":"e07996","DOI":"10.1016\/j.heliyon.2021.e07996","volume":"7","author":"M Doshmanziari","year":"2021","unstructured":"Doshmanziari M, Shirian S, Kouchakian MR, Moniri SF, Jangnoo S, Mohammadi N, Zafari F. Mesenchymal stem cells act as stimulators of neurogenesis and synaptic function in a rat model of Alzheimer\u2019s disease. Heliyon. 2021;7:e07996.","journal-title":"Heliyon"},{"key":"4285_CR129","doi-asserted-by":"publisher","first-page":"7834421","DOI":"10.1155\/2021\/7834421","volume":"2021","author":"AE Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez AE, Garc\u00eda E. Mesenchymal stem cell therapy for Alzheimer\u2019s disease. Stem Cells Int. 2021;2021:7834421.","journal-title":"Stem Cells Int"},{"key":"4285_CR130","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4161\/auto.26508","volume":"10","author":"JY Shin","year":"2014","unstructured":"Shin JY, Park HJ, Kim HN, Oh SH, Bae JS, Ha HJ, Lee PH. Mesenchymal stem cells enhance autophagy and increase \u03b2-amyloid clearance in alzheimer disease models. Autophagy. 2014;10:32\u201344.","journal-title":"Autophagy"},{"key":"4285_CR131","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G, Brandi E, Vitola P, Grandi F, Ferrara G, Pischiutta F, Vegliante G, Zanier ER, Re F, Uccelli A, Forloni G, de Rosbo NK, Balducci C. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ. 2021;28:203\u201318.","journal-title":"Cell Death Differ"},{"key":"4285_CR132","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s11064-017-2226-8","volume":"42","author":"XY Zheng","year":"2017","unstructured":"Zheng XY, Wan QQ, Zheng CY, Zhou HL, Dong XY, Deng QS, Yao H, Fu Q, Gao M, Yan ZJ, Wang SS, You Y, Lv J, Wang XY, Chen KE, Zhang MY, Xu RX. Amniotic mesenchymal stem cells decrease A\u03b2 deposition and improve memory in APP\/PS1 Transgenic mice. Neurochem Res. 2017;42:2191\u2013207.","journal-title":"Neurochem Res"},{"key":"4285_CR133","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trci.2015.06.007","volume":"1","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, Choi SJ, Kwon H, Yun HJ, Lee JM, Kim ST, Choe YS, Lee KH, Na DL. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: A phase 1 clinical trial. Alzheimers Dement (N Y). 2015;1:95\u2013102.","journal-title":"Alzheimers Dement (N Y)"},{"key":"4285_CR134","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","volume":"13","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, Moon SW, Seo SW, Choi SJ, Na DL. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021;13:154.","journal-title":"Alzheimers Res Ther"},{"issue":"Suppl 1","key":"4285_CR135","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.3727\/096368914X684970","volume":"23","author":"L Danielyan","year":"2014","unstructured":"Danielyan L, Beer-Hammer S, Stolzing A, Sch\u00e4fer R, Siegel G, Fabian C, Kahle P, Biedermann T, Lourhmati A, Buadze M, Novakovic A, Proksch B, Gleiter CH, Frey WH, Schwab M. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer\u2019s and Parkinson\u2019s disease. Cell Transpl. 2014;23(Suppl 1):S123\u201339.","journal-title":"Cell Transpl"},{"key":"4285_CR136","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","volume":"155","author":"NK Venkataramana","year":"2010","unstructured":"Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson\u2019s disease. Transl Res. 2010;155:62\u201370.","journal-title":"Transl Res"},{"key":"4285_CR137","doi-asserted-by":"publisher","first-page":"380","DOI":"10.25259\/SNI_233_2020","volume":"11","author":"A Boika","year":"2020","unstructured":"Boika A, Aleinikava N, Chyzhyk V, Zafranskaya M, Nizheharodava D, Ponomarev V. Mesenchymal stem cells in Parkinson\u2019s disease: motor and nonmotor symptoms in the early posttransplant period. Surg Neurol Int. 2020;11:380.","journal-title":"Surg Neurol Int"},{"key":"4285_CR138","doi-asserted-by":"crossref","unstructured":"Gavasso S, Kr\u00e5kenes T, Olsen H, Evjenth EC, Ytterdal M, Haugs\u00f8en JB, Kvistad CE. The therapeutic mechanisms of mesenchymal stem cells in MS-A review focusing on neuroprotective properties. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms25031365"},{"key":"4285_CR139","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/stcltm\/szad095","volume":"13","author":"SH Kim","year":"2024","unstructured":"Kim SH, Oh KW, Noh MY, Kwon MS. Optimal therapeutic strategy of bone Marrow-Originated autologous mesenchymal stromal\/stem cells for ALS. Stem Cells Transl Med. 2024;13:309\u201316.","journal-title":"Stem Cells Transl Med"},{"key":"4285_CR140","doi-asserted-by":"publisher","first-page":"101764","DOI":"10.1016\/j.isci.2020.101764","volume":"23","author":"T Terashima","year":"2020","unstructured":"Terashima T, Kobashi S, Watanabe Y, Nakanishi M, Honda N, Katagi M, Ohashi N, Kojima H. Enhancing the therapeutic efficacy of bone Marrow-Derived mononuclear cells with growth Factor-Expressing mesenchymal stem cells for ALS in mice. iScience. 2020;23:101764.","journal-title":"iScience"},{"key":"4285_CR141","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2011.08.036","volume":"313","author":"VK Harris","year":"2012","unstructured":"Harris VK, Yan QJ, Vyshkina T, Sahabi S, Liu X, Sadiq SA. Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis. J Neurol Sci. 2012;313:167\u201377.","journal-title":"J Neurol Sci"},{"key":"4285_CR142","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3727\/096368916X693716","volume":"26","author":"E Sykov\u00e1","year":"2017","unstructured":"Sykov\u00e1 E, Rychmach P, Drahor\u00e1dov\u00e1 I, Konr\u00e1dov\u00e1 \u0160, R\u016f\u017ei\u010dkov\u00e1 K, Vo\u0159\u00ed\u0161ek I, Forostyak S, Homola A, Bojar M. Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I\/IIa clinical trial. Cell Transpl. 2017;26:647\u201358.","journal-title":"Cell Transpl"},{"key":"4285_CR143","doi-asserted-by":"publisher","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","volume":"93","author":"JD Berry","year":"2019","unstructured":"Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, McKenna-Yasek D, Levy YS, Abramov N, Kaspi H, Mehra M, Aricha R, Gothelf Y, Brown RH, NurOwn. Phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results. Neurology. 2019;93:e2294\u2013305.","journal-title":"Neurology"},{"key":"4285_CR144","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/mus.27472","volume":"65","author":"ME Cudkowicz","year":"2022","unstructured":"Cudkowicz ME, Lindborg SR, Goyal NA, Miller RG, Burford MJ, Berry JD, Nicholson KA, Mozaffar T, Katz JS, Jenkins LJ, Baloh RH, Lewis RA, Staff NP, Owegi MA, Berry DA, Gothelf Y, Levy YS, Aricha R, Kern RZ, Windebank AJ, Brown RH. Jr. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Muscle Nerve. 2022;65:291\u2013302.","journal-title":"Muscle Nerve"},{"key":"4285_CR145","doi-asserted-by":"publisher","first-page":"693","DOI":"10.52586\/4980","volume":"26","author":"P Petrou","year":"2021","unstructured":"Petrou P, Kassis I, Yaghmour NE, Ginzberg A, Karussis D. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis. Front Biosci (Landmark Ed). 2021;26:693\u2013706.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4285_CR146","doi-asserted-by":"publisher","first-page":"716853","DOI":"10.3389\/fcell.2021.716853","volume":"9","author":"M Najar","year":"2021","unstructured":"Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, Fahmi H, Lewalle P, Fayyad-Kazan M, Merimi M. Therapeutic mesenchymal stem\/stromal cells: value, challenges and optimization. Front Cell Dev Biol. 2021;9:716853.","journal-title":"Front Cell Dev Biol"},{"key":"4285_CR147","doi-asserted-by":"publisher","first-page":"eaba6884","DOI":"10.1126\/sciadv.aba6884","volume":"6","author":"O Levy","year":"2020","unstructured":"Levy O, Kuai R, Siren EMJ, Bhere D, Milton Y, Nissar N, De Biasio M, Heinelt M, Reeve B, Abdi R, Alturki M, Fallatah M, Almalik A, Alhasan AH, Shah K, Karp JM. Shattering barriers toward clinically meaningful MSC therapies. Sci Adv. 2020;6:eaba6884.","journal-title":"Sci Adv"},{"key":"4285_CR148","doi-asserted-by":"publisher","first-page":"918565","DOI":"10.3389\/fimmu.2022.918565","volume":"13","author":"ME Fern\u00e1ndez-Santos","year":"2022","unstructured":"Fern\u00e1ndez-Santos ME, Garcia-Arranz M, Andreu EJ, Garc\u00eda-Hern\u00e1ndez AM, L\u00f3pez-Parra M, Villar\u00f3n E, Sep\u00falveda P, Fern\u00e1ndez-Avil\u00e9s F, Garc\u00eda-Olmo D, Prosper F, S\u00e1nchez-Guijo F, Moraleda JM, Zapata AG. Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome. Front Immunol. 2022;13:918565.","journal-title":"Front Immunol"},{"key":"4285_CR149","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.actbio.2021.03.069","volume":"133","author":"CM Dunn","year":"2021","unstructured":"Dunn CM, Kameishi S, Grainger DW, Okano T. Strategies to address mesenchymal stem\/stromal cell heterogeneity in Immunomodulatory profiles to improve cell-based therapies. Acta Biomater. 2021;133:114\u201325.","journal-title":"Acta Biomater"},{"key":"4285_CR150","doi-asserted-by":"publisher","first-page":"1329712","DOI":"10.3389\/fbioe.2024.1329712","volume":"12","author":"L Yang","year":"2024","unstructured":"Yang L, Liu SC, Liu YY, Zhu FQ, Xiong MJ, Hu DX, Zhang WJ. Therapeutic role of neural stem cells in neurological diseases. Front Bioeng Biotechnol. 2024;12:1329712.","journal-title":"Front Bioeng Biotechnol"},{"key":"4285_CR151","first-page":"727542","volume":"2015","author":"J Zhang","year":"2015","unstructured":"Zhang J, Jiao J. Molecular biomarkers for embryonic and adult neural stem cell and neurogenesis. Biomed Res Int. 2015;2015:727542.","journal-title":"Biomed Res Int"},{"key":"4285_CR152","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fcell.2020.00815","volume":"8","author":"AA Galiakberova","year":"2020","unstructured":"Galiakberova AA, Dashinimaev EB. Neural stem cells and methods for their generation from induced pluripotent stem cells in vitro. Front Cell Dev Biol. 2020;8:815.","journal-title":"Front Cell Dev Biol"},{"key":"4285_CR153","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1002\/1873-3468.13656","volume":"593","author":"A Erharter","year":"2019","unstructured":"Erharter A, Rizzi S, Mertens J, Edenhofer F. Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications. FEBS Lett. 2019;593:3353\u201369.","journal-title":"FEBS Lett"},{"key":"4285_CR154","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.stem.2020.07.002","volume":"27","author":"P Navarro Negredo","year":"2020","unstructured":"Navarro Negredo P, Yeo RW, Brunet A. Aging and rejuvenation of neural stem cells and their niches. Cell Stem Cell. 2020;27:202\u201323.","journal-title":"Cell Stem Cell"},{"key":"4285_CR155","doi-asserted-by":"publisher","first-page":"101636","DOI":"10.1016\/j.arr.2022.101636","volume":"78","author":"L Culig","year":"2022","unstructured":"Culig L, Chu X, Bohr VA. Neurogenesis in aging and age-related neurodegenerative diseases. Ageing Res Rev. 2022;78:101636.","journal-title":"Ageing Res Rev"},{"key":"4285_CR156","doi-asserted-by":"publisher","unstructured":"Velikic G, Maric DM, Maric DL, Supic G, Puletic M, Dulic O, Vojvodic D. Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases. Int J Mol Sci. 2024;25(2):993. https:\/\/doi.org\/10.3390\/ijms25020993","DOI":"10.3390\/ijms25020993"},{"key":"4285_CR157","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcell.2017.00052","volume":"5","author":"L Ottoboni","year":"2017","unstructured":"Ottoboni L, Merlini A, Martino G. Neural stem cell plasticity: advantages in therapy for the injured central nervous system. Front Cell Dev Biol. 2017;5:52.","journal-title":"Front Cell Dev Biol"},{"key":"4285_CR158","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/term.1972","volume":"11","author":"S Knippenberg","year":"2017","unstructured":"Knippenberg S, Rath KJ, B\u00f6selt S, Thau-Habermann N, Schwarz SC, Dengler R, Wegner F, Petri S. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors. J Tissue Eng Regen Med. 2017;11:751\u201364.","journal-title":"J Tissue Eng Regen Med"},{"key":"4285_CR159","doi-asserted-by":"publisher","first-page":"165ra164","DOI":"10.1126\/scitranslmed.3004579","volume":"4","author":"YD Teng","year":"2012","unstructured":"Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, Lachyankar MB, Marconi M, Li J, Yu D, Han I, Maragakis NJ, Ll\u00e1do J, Erkmen K, Redmond DE Jr., Sidman RL, Przedborski S, Rothstein JD, Brown RH. Jr. and snyder EY. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med. 2012;4:165ra164.","journal-title":"Sci Transl Med"},{"key":"4285_CR160","doi-asserted-by":"crossref","unstructured":"Forostyak S, Forostyak O, Kwok JCF, Romanyuk N, Rehorova M, Kriska J, Dayanithi G, Raha-Chowdhury R, Jendelova P, Anderova M, Fawcett JW, Sykova E. Transplantation of neural precursors derived from induced pluripotent cells preserve perineuronal Nets and stimulate neural plasticity in ALS rats. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21249593"},{"key":"4285_CR161","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/stem.1079","volume":"30","author":"JD Glass","year":"2012","unstructured":"Glass JD, Boulis NM, Johe K, Rutkove SB, Federici T, Polak M, Kelly C, Feldman EL. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells. 2012;30:1144\u201351.","journal-title":"Stem Cells"},{"key":"4285_CR162","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.24113","volume":"75","author":"EL Feldman","year":"2014","unstructured":"Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J, Sakowski SA, Glass JD. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann Neurol. 2014;75:363\u201373.","journal-title":"Ann Neurol"},{"key":"4285_CR163","doi-asserted-by":"crossref","unstructured":"Riley J, Federici T, Polak M, Kelly C, Glass J, Raore B, Taub J, Kesner V, Feldman EL, Boulis NM. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery. 2012;71:405\u2013\u200916; discussion 416.","DOI":"10.1227\/NEU.0b013e31825ca05f"},{"key":"4285_CR164","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","volume":"13","author":"L Mazzini","year":"2015","unstructured":"Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, Ricciolini C, Rota Nodari L, Carletti S, Giorgi C, Spera C, Domenico F, Bersano E, Petruzzelli F, Cisari C, Maglione A, Sarnelli MF, Stecco A, Querin G, Masiero S, Cantello R, Ferrari D, Zalfa C, Binda E, Visioli A, Trombetta D, Novelli A, Torres B, Bernardini L, Carriero A, Prandi P, Servo S, Cerino A, Cima V, Gaiani A, Nasuelli N, Massara M, Glass J, Sorar\u00f9 G, Boulis NM, Vescovi AL. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;13:17.","journal-title":"J Transl Med"},{"key":"4285_CR165","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41591-022-01956-3","volume":"28","author":"RH Baloh","year":"2022","unstructured":"Baloh RH, Johnson JP, Avalos P, Allred P, Svendsen S, Gowing G, Roxas K, Wu A, Donahue B, Osborne S, Lawless G, Shelley B, Wheeler K, Prina C, Fine D, Kendra-Romito T, Stokes H, Manoukian V, Muthukumaran A, Garcia L, Ba\u00f1uelos MG, Godoy M, Bresee C, Yu H, Drazin D, Ross L, Naruse R, Babu H, Macklin EA, Vo A, Elsayegh A, Tourtellotte W, Maya M, Burford M, Diaz F, Patil CG, Lewis RA, Svendsen CN. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial. Nat Med. 2022;28:1813\u201322.","journal-title":"Nat Med"},{"key":"4285_CR166","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","volume":"30","author":"MA Leone","year":"2023","unstructured":"Leone MA, Gelati M, Profico DC, Gobbi C, Pravat\u00e0 E, Copetti M, Conti C, Abate L, Amoruso L, Apollo F, Balzano RF, Bicchi I, Carella M, Ciampini A, Colosimo C, Crociani P, D\u2019Aloisio G, Di Viesti P, Ferrari D, Fogli D, Fontana A, Frondizi D, Grespi V, Kuhle J, Laborante A, Lombardi I, Muzi G, Paci F, Placentino G, Popolizio T, Ricciolini C, Sabatini S, Silveri G, Spera C, Stephenson D, Stipa G, Tinella E, Zarrelli M, Zecca C, Ventura Y, D\u2019Alessandro A, Peruzzotti-Jametti L, Pluchino S, Vescovi AL. Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell. 2023;30:1597\u2013e16098.","journal-title":"Cell Stem Cell"},{"key":"4285_CR167","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/sctm.18-0154","volume":"8","author":"L Mazzini","year":"2019","unstructured":"Mazzini L, Gelati M, Profico DC, Sorar\u00f9 G, Ferrari D, Copetti M, Muzi G, Ricciolini C, Carletti S, Giorgi C, Spera C, Frondizi D, Masiero S, Stecco A, Cisari C, Bersano E, De Marchi F, Sarnelli MF, Querin G, Cantello R, Petruzzelli F, Maglione A, Zalfa C, Binda E, Visioli A, Trombetta D, Torres B, Bernardini L, Gaiani A, Massara M, Paolucci S, Boulis NM, Vescovi AL. Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: A Long-Term outcome. Stem Cells Transl Med. 2019;8:887\u201397.","journal-title":"Stem Cells Transl Med"},{"key":"4285_CR168","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1212\/WNL.0000000000002889","volume":"87","author":"JD Glass","year":"2016","unstructured":"Glass JD, Hertzberg VS, Boulis NM, Riley J, Federici T, Polak M, Bordeau J, Fournier C, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges LF, Rutkove SB, Duell J, Patil PG, Goutman SA, Feldman EL. Transplantation of spinal cord-derived neural stem cells for ALS: analysis of phase 1 and 2 trials. Neurology. 2016;87:392\u2013400.","journal-title":"Neurology"},{"key":"4285_CR169","doi-asserted-by":"publisher","first-page":"146615","DOI":"10.1016\/j.brainres.2019.146615","volume":"1729","author":"CM Willis","year":"2020","unstructured":"Willis CM, Nicaise AM, Peruzzotti-Jametti L, Pluchino S. The neural stem cell secretome and its role in brain repair. Brain Res. 2020;1729:146615.","journal-title":"Brain Res"},{"key":"4285_CR170","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12951-022-01356-2","volume":"20","author":"EJ Lee","year":"2022","unstructured":"Lee EJ, Choi Y, Lee HJ, Hwang DW, Lee DS. Human neural stem cell-derived extracellular vesicles protect against Parkinson\u2019s disease pathologies. J Nanobiotechnol. 2022;20:198.","journal-title":"J Nanobiotechnol"},{"key":"4285_CR171","doi-asserted-by":"publisher","first-page":"147978","DOI":"10.1016\/j.brainres.2022.147978","volume":"1790","author":"W Ni","year":"2022","unstructured":"Ni W, Zhou J, Ling Y, Lu X, Niu D, Zeng Y, Qiu Y, Si Y, Wang J, Zhang W, Wang Z, Hu J. Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson\u2019s disease model. Brain Res. 2022;1790:147978.","journal-title":"Brain Res"},{"key":"4285_CR172","doi-asserted-by":"publisher","first-page":"102086","DOI":"10.1016\/j.pneurobio.2021.102086","volume":"204","author":"SW Kim","year":"2021","unstructured":"Kim SW, Woo HJ, Kim EH, Kim HS, Suh HN, Kim SH, Song JJ, Wulansari N, Kang M, Choi SY, Choi SJ, Jang WH, Lee J, Kim KH, Lee W, Kim SH, Yang J, Kyung J, Lee HS, Park SM, Chang MY, Lee SH. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson\u2019s disease: midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment. Prog Neurobiol. 2021;204:102086.","journal-title":"Prog Neurobiol"},{"key":"4285_CR173","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00018-014-1774-1","volume":"72","author":"JN Le Grand","year":"2015","unstructured":"Le Grand JN, Gonzalez-Cano L, Pavlou MA, Schwamborn JC. Neural stem cells in Parkinson\u2019s disease: a role for neurogenesis defects in onset and progression. Cell Mol Life Sci. 2015;72:773\u201397.","journal-title":"Cell Mol Life Sci"},{"key":"4285_CR174","doi-asserted-by":"crossref","unstructured":"Choi DH, Kim JH, Kim SM, Kang K, Han DW, Lee J. Therapeutic Potential of Induced Neural Stem Cells for Parkinson\u2019s Disease. Int J Mol Sci. 2017;18.","DOI":"10.3390\/ijms18010224"},{"key":"4285_CR175","doi-asserted-by":"publisher","first-page":"773925","DOI":"10.3389\/fphar.2021.773925","volume":"12","author":"A Nelke","year":"2021","unstructured":"Nelke A, Garc\u00eda-L\u00f3pez S, Mart\u00ednez-Serrano A, Pereira MP. Multifactoriality of Parkinson\u2019s disease as explored through human neural stem cells and their transplantation in Middle-Aged parkinsonian mice. Front Pharmacol. 2021;12:773925.","journal-title":"Front Pharmacol"},{"key":"4285_CR176","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0963689718820271","volume":"28","author":"I Madrazo","year":"2019","unstructured":"Madrazo I, Kopyov O, \u00c1vila-Rodr\u00edguez MA, Ostrosky F, Carrasco H, Kopyov A, Avenda\u00f1o-Estrada A, Jim\u00e9nez F, Magall\u00f3n E, Zamorano C, Gonz\u00e1lez G, Valenzuela T, Carrillo R, Palma F, Rivera R. Franco-Bourland RE and Gu\u00edzar-Sahag\u00fan G. Transplantation of human neural progenitor cells (NPC) into putamina of parkinsonian patients: A case series study, safety and efficacy four years after surgery. Cell Transpl. 2019;28:269\u201385.","journal-title":"Cell Transpl"},{"key":"4285_CR177","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.scib.2023.10.020","volume":"68","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zhao G. First-in-human transplantation of autologous induced neural stem cell-derived dopaminergic precursors to treat Parkinson\u2019s disease. Sci Bull (Beijing). 2023;68:2700\u20133.","journal-title":"Sci Bull (Beijing)"},{"key":"4285_CR178","first-page":"378","volume":"26","author":"L Lige","year":"2016","unstructured":"Lige L, Zengmin T. Transplantation of neural precursor cells in the treatment of Parkinson disease: an efficacy and safety analysis. Turk Neurosurg. 2016;26:378\u201383.","journal-title":"Turk Neurosurg"},{"key":"4285_CR179","doi-asserted-by":"publisher","first-page":"113112","DOI":"10.1016\/j.expneurol.2019.113112","volume":"324","author":"AC Boese","year":"2020","unstructured":"Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in Alzheimer\u2019s disease. Exp Neurol. 2020;324:113112.","journal-title":"Exp Neurol"},{"key":"4285_CR180","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fnagi.2016.00282","volume":"8","author":"X Li","year":"2016","unstructured":"Li X, Zhu H, Sun X, Zuo F, Lei J, Wang Z, Bao X, Wang R. Human neural stem cell transplantation rescues cognitive defects in APP\/PS1 model of Alzheimer\u2019s disease by enhancing neuronal connectivity and metabolic activity. Front Aging Neurosci. 2016;8:282.","journal-title":"Front Aging Neurosci"},{"key":"4285_CR181","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neulet.2008.05.107","volume":"440","author":"AG Xuan","year":"2008","unstructured":"Xuan AG, Long DH, Gu HG, Yang DD, Hong LP, Leng SL. BDNF improves the effects of neural stem cells on the rat model of Alzheimer\u2019s disease with unilateral lesion of fimbria-fornix. Neurosci Lett. 2008;440:331\u20135.","journal-title":"Neurosci Lett"},{"key":"4285_CR182","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12640-018-9884-4","volume":"34","author":"MJ Ebrahimi","year":"2018","unstructured":"Ebrahimi MJ, Aliaghaei A, Boroujeni ME, Khodagholi F, Meftahi G, Abdollahifar MA, Ahmadi H, Danyali S, Daftari M, Sadeghi Y. Human umbilical cord matrix stem cells reverse oxidative Stress-Induced cell death and ameliorate motor function and striatal atrophy in rat model of huntington disease. Neurotox Res. 2018;34:273\u201384.","journal-title":"Neurotox Res"},{"key":"4285_CR183","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"XL Fan","year":"2020","unstructured":"Fan XL, Zhang Y, Li X, Fu QL. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020;77:2771\u201394.","journal-title":"Cell Mol Life Sci"},{"key":"4285_CR184","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.4252\/wjsc.v13.i9.1278","volume":"13","author":"L Zhao","year":"2021","unstructured":"Zhao L, Liu JW, Shi HY, Ma YM. Neural stem cell therapy for brain disease. World J Stem Cells. 2021;13:1278\u201392.","journal-title":"World J Stem Cells"},{"key":"4285_CR185","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4103\/1673-5374.380874","volume":"19","author":"J Chang","year":"2024","unstructured":"Chang J, Li Y, Shan X, Chen X, Yan X, Liu J, Zhao L. Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of Alzheimer\u2019s disease. Neural Regen Res. 2024;19:619\u201328.","journal-title":"Neural Regen Res"},{"key":"4285_CR186","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41536-017-0033-0","volume":"2","author":"S Grade","year":"2017","unstructured":"Grade S, G\u00f6tz M. Neuronal replacement therapy: previous achievements and challenges ahead. NPJ Regen Med. 2017;2:29.","journal-title":"NPJ Regen Med"},{"key":"4285_CR187","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.conb.2021.03.014","volume":"69","author":"M G\u00f6tz","year":"2021","unstructured":"G\u00f6tz M, Bocchi R. Neuronal replacement: concepts, achievements, and call for caution. Curr Opin Neurobiol. 2021;69:185\u201392.","journal-title":"Curr Opin Neurobiol"},{"key":"4285_CR188","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.stem.2016.09.004","volume":"20","author":"A Kirkeby","year":"2017","unstructured":"Kirkeby A, Nolbrant S, Tiklova K, Heuer A, Kee N, Cardoso T, Ottosson DR, Lelos MJ, Rifes P, Dunnett SB, Grealish S, Perlmann T, Parmar M. Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-Based therapy for Parkinson\u2019s disease. Cell Stem Cell. 2017;20:135\u201348.","journal-title":"Cell Stem Cell"},{"key":"4285_CR189","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.stem.2020.08.014","volume":"28","author":"M Xiong","year":"2021","unstructured":"Xiong M, Tao Y, Gao Q, Feng B, Yan W, Zhou Y, Kotsonis TA, Yuan T, You Z, Wu Z, Xi J, Haberman A, Graham J, Block J, Zhou W, Chen Y, Zhang SC. Human stem Cell-Derived neurons repair circuits and restore neural function. Cell Stem Cell. 2021;28:112\u2013e1266.","journal-title":"Cell Stem Cell"},{"key":"4285_CR190","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1016\/j.celrep.2019.08.058","volume":"28","author":"AF Adler","year":"2019","unstructured":"Adler AF, Cardoso T, Nolbrant S, Mattsson B, Hoban DB, Jarl U, Wahlestedt JN, Grealish S. Bj\u00f6rklund A and Parmar M. hESC-Derived dopaminergic transplants integrate into basal ganglia circuitry in a preclinical model of Parkinson\u2019s disease. Cell Rep. 2019;28:3462\u2013e34735.","journal-title":"Cell Rep"},{"key":"4285_CR191","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/cne.24500","volume":"526","author":"T Cardoso","year":"2018","unstructured":"Cardoso T, Adler AF, Mattsson B, Hoban DB, Nolbrant S, Wahlestedt JN, Kirkeby A, Grealish S, Bj\u00f6rklund A, Parmar M. Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats. J Comp Neurol. 2018;526:2133\u201346.","journal-title":"J Comp Neurol"},{"key":"4285_CR192","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","volume":"10","author":"L Ma","year":"2012","unstructured":"Ma L, Hu B, Liu Y, Vermilyea SC, Liu H, Gao L, Sun Y, Zhang X, Zhang SC. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell. 2012;10:455\u201364.","journal-title":"Cell Stem Cell"},{"key":"4285_CR193","doi-asserted-by":"publisher","first-page":"798","DOI":"10.4103\/1673-5374.131596","volume":"9","author":"Y Yan","year":"2014","unstructured":"Yan Y, Ma T, Gong K, Ao Q, Zhang X, Gong Y. Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer\u2019s disease mice. Neural Regen Res. 2014;9:798\u2013805.","journal-title":"Neural Regen Res"},{"key":"4285_CR194","doi-asserted-by":"crossref","unstructured":"Park H, Chang KA. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson\u2019s Disease Mouse Model. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21218129"},{"key":"4285_CR195","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","volume":"13","author":"M Miranda","year":"2019","unstructured":"Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-Derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019;13:363.","journal-title":"Front Cell Neurosci"},{"key":"4285_CR196","doi-asserted-by":"publisher","first-page":"1903809","DOI":"10.1002\/advs.201903809","volume":"7","author":"Y Jia","year":"2020","unstructured":"Jia Y, Cao N, Zhai J, Zeng Q, Zheng P, Su R, Liao T, Liu J, Pei H, Fan Z, Zhou J, Xi J, He L, Chen L, Nan X, Yue W, Pei X. HGF mediates Clinical-Grade human umbilical Cord-Derived mesenchymal stem cells improved functional recovery in a Senescence-Accelerated mouse model of Alzheimer\u2019s disease. Adv Sci (Weinh). 2020;7:1903809.","journal-title":"Adv Sci (Weinh)"},{"key":"4285_CR197","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1089\/scd.2014.0487","volume":"24","author":"DH Kim","year":"2015","unstructured":"Kim DH, Lee D, Chang EH, Kim JH, Hwang JW, Kim JY, Kyung JW, Kim SH, Oh JS, Shim SM, Na DL, Oh W, Chang JW. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer\u2019s disease model. Stem Cells Dev. 2015;24:2378\u201390.","journal-title":"Stem Cells Dev"},{"key":"4285_CR198","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/01616412.2020.1783473","volume":"42","author":"R Xu","year":"2020","unstructured":"Xu R, Wu J, Lang L, Hu J, Tang H, Xu J, Sun B. Implantation of glial cell line-derived neurotrophic factor-expressing adipose tissue-derived stromal cells in a rat Parkinson\u2019s disease model. Neurol Res. 2020;42:712\u201320.","journal-title":"Neurol Res"},{"key":"4285_CR199","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnagi.2014.00030","volume":"6","author":"KO Garcia","year":"2014","unstructured":"Garcia KO, Ornellas FL, Martin PK, Patti CL, Mello LE, Frussa-Filho R, Han SW, Longo BM. Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:30.","journal-title":"Front Aging Neurosci"},{"key":"4285_CR200","first-page":"245","volume":"7","author":"P Zhang","year":"2012","unstructured":"Zhang P, Zhao G, Kang X, Su L. Effects of lateral ventricular transplantation of bone marrow-derived mesenchymal stem cells modified with brain-derived neurotrophic factor gene on cognition in a rat model of Alzheimer\u2019s disease. Neural Regen Res. 2012;7:245\u201350.","journal-title":"Neural Regen Res"},{"key":"4285_CR201","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/01616412.2020.1834775","volume":"43","author":"J Wang","year":"2021","unstructured":"Wang J, Hu W, Feng Z, Feng M. BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice. Neurol Res. 2021;43:199\u2013209.","journal-title":"Neurol Res"},{"key":"4285_CR202","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3389\/fphys.2019.00486","volume":"10","author":"S P\u00f6yh\u00f6nen","year":"2019","unstructured":"P\u00f6yh\u00f6nen S, Er S, Domanskyi A, Airavaara M. Effects of neurotrophic factors in glial cells in the central nervous system: expression and properties in neurodegeneration and injury. Front Physiol. 2019;10:486.","journal-title":"Front Physiol"},{"key":"4285_CR203","doi-asserted-by":"publisher","first-page":"986443","DOI":"10.3389\/fnagi.2022.986443","volume":"14","author":"Y Li","year":"2022","unstructured":"Li Y, Li F, Qin D, Chen H, Wang J, Wang J, Song S, Wang C, Wang Y, Liu S, Gao D, Wang ZH. The role of brain derived neurotrophic factor in central nervous system. Front Aging Neurosci. 2022;14:986443.","journal-title":"Front Aging Neurosci"},{"key":"4285_CR204","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11910-017-0733-2","volume":"17","author":"M Schain","year":"2017","unstructured":"Schain M, Kreisl WC. Neuroinflammation in neurodegenerative Disorders-a review. Curr Neurol Neurosci Rep. 2017;17:25.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4285_CR205","doi-asserted-by":"publisher","first-page":"9999146","DOI":"10.1155\/2021\/9999146","volume":"2021","author":"R K\u00f6lliker-Frers","year":"2021","unstructured":"K\u00f6lliker-Frers R, Udovin L, Otero-Losada M, Kobiec T, Herrera MI, Palacios J, Razzitte G, Capani F. Neuroinflammation: an integrating overview of Reactive-Neuroimmune cell interactions in health and disease. Mediators Inflamm. 2021;2021:9999146.","journal-title":"Mediators Inflamm"},{"key":"4285_CR206","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8:267.","journal-title":"Signal Transduct Target Ther"},{"key":"4285_CR207","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/cdd.2012.26","volume":"19","author":"W Li","year":"2012","unstructured":"Li W, Ren G, Huang Y, Su J, Han Y, Li J, Chen X, Cao K, Chen Q, Shou P, Zhang L, Yuan ZR, Roberts AI, Shi S, Le AD, Shi Y. Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ. 2012;19:1505\u201313.","journal-title":"Cell Death Differ"},{"key":"4285_CR208","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41598-020-58221-1","volume":"10","author":"MG Kook","year":"2020","unstructured":"Kook MG, Lee S, Shin N, Kong D, Kim DH, Kim MS, Kang HK, Choi SW, Kang KS. Repeated intramuscular transplantations of hUCB-MSCs improves motor function and survival in the SOD1 G(93)A mice through activation of AMPK. Sci Rep. 2020;10:1572.","journal-title":"Sci Rep"},{"key":"4285_CR209","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.scr.2017.11.005","volume":"25","author":"F Sironi","year":"2017","unstructured":"Sironi F, Vallarola A, Violatto MB, Talamini L, Freschi M, De Gioia R, Capelli C, Agostini A, Moscatelli D, Tortarolo M, Bigini P, Introna M, Bendotti C. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice. Stem Cell Res. 2017;25:166\u201378.","journal-title":"Stem Cell Res"},{"key":"4285_CR210","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tins.2024.04.003","volume":"47","author":"W Zhang","year":"2024","unstructured":"Zhang W, Sun HS, Wang X, Dumont AS, Liu Q. Cellular senescence, DNA damage, and neuroinflammation in the aging brain. Trends Neurosci. 2024;47:461\u201374.","journal-title":"Trends Neurosci"},{"key":"4285_CR211","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40478-018-0644-8","volume":"6","author":"N Boukelmoune","year":"2018","unstructured":"Boukelmoune N, Chiu GS, Kavelaars A, Heijnen CJ. Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin. Acta Neuropathol Commun. 2018;6:139.","journal-title":"Acta Neuropathol Commun"},{"key":"4285_CR212","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.7150\/thno.29400","volume":"9","author":"H Li","year":"2019","unstructured":"Li H, Wang C, He T, Zhao T, Chen YY, Shen YL, Zhang X, Wang LL. Mitochondrial transfer from bone marrow mesenchymal stem cells to motor neurons in spinal cord injury rats via gap junction. Theranostics. 2019;9:2017\u201335.","journal-title":"Theranostics"},{"key":"4285_CR213","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez VJ, Mart\u00edn-Rodr\u00edguez A, Y\u00e1\u00f1ez-Sep\u00falveda R, Tornero-Aguilera JF. Mitochondrial transfer as a novel therapeutic approach in disease diagnosis and treatment. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24108848"},{"key":"4285_CR214","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.neuron.2017.03.008","volume":"93","author":"R Beckervordersandforth","year":"2017","unstructured":"Beckervordersandforth R, Ebert B, Sch\u00e4ffner I, Moss J, Fiebig C, Shin J, Moore DL, Ghosh L, Trinchero MF, Stockburger C, Friedland K, Steib K, von Wittgenstein J, Keiner S, Redecker C, H\u00f6lter SM, Xiang W, Wurst W, Jagasia R, Schinder AF, Ming GL, Toni N, Jessberger S, Song H, Lie DC. Role of mitochondrial metabolism in the control of early lineage progression and aging phenotypes in adult hippocampal neurogenesis. Neuron. 2017;93:1518.","journal-title":"Neuron"},{"key":"4285_CR215","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12929-018-0429-1","volume":"25","author":"S Paliwal","year":"2018","unstructured":"Paliwal S, Chaudhuri R, Agrawal A, Mohanty S. Regenerative abilities of mesenchymal stem cells through mitochondrial transfer. J Biomed Sci. 2018;25:31.","journal-title":"J Biomed Sci"},{"key":"4285_CR216","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/stcltm\/szac044","volume":"11","author":"YL Tan","year":"2022","unstructured":"Tan YL, Eng SP, Hafez P, Abdul Karim N, Law JX, Ng MH. Mesenchymal stromal cell mitochondrial transfer as a cell rescue strategy in regenerative medicine: A review of evidence in preclinical models. Stem Cells Transl Med. 2022;11:814\u201327.","journal-title":"Stem Cells Transl Med"},{"key":"4285_CR217","doi-asserted-by":"publisher","first-page":"151289","DOI":"10.1016\/j.ejcb.2023.151289","volume":"102","author":"A Branco","year":"2023","unstructured":"Branco A, Moniz I, Ramalho-Santos J. Mitochondria as biological targets for stem cell and organismal senescence. Eur J Cell Biol. 2023;102:151289.","journal-title":"Eur J Cell Biol"},{"key":"4285_CR218","doi-asserted-by":"publisher","first-page":"113738","DOI":"10.1016\/j.celrep.2024.113738","volume":"43","author":"D Choudhury","year":"2024","unstructured":"Choudhury D, Rong N, Senthil Kumar HV, Swedick S, Samuel RZ, Mehrotra P, Toftegaard J, Rajabian N, Thiyagarajan R, Podder AK, Wu Y, Shahini S, Seldeen KL, Troen B. Lei P and Andreadis ST. Proline restores mitochondrial function and reverses aging hallmarks in senescent cells. Cell Rep. 2024;43:113738.","journal-title":"Cell Rep"},{"key":"4285_CR219","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41580-021-00335-z","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang H, Yang Y, Liu J, Qian L. Direct cell reprogramming: approaches, mechanisms and progress. Nat Rev Mol Cell Biol. 2021;22:410\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4285_CR220","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.stem.2015.01.013","volume":"16","author":"J Xu","year":"2015","unstructured":"Xu J, Du Y, Deng H. Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell. 2015;16:119\u201334.","journal-title":"Cell Stem Cell"},{"key":"4285_CR221","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/5584_2019_374","volume":"1212","author":"J Bajohr","year":"2020","unstructured":"Bajohr J, Faiz M. Direct lineage reprogramming in the CNS. Adv Exp Med Biol. 2020;1212:31\u201348.","journal-title":"Adv Exp Med Biol"},{"key":"4285_CR222","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.neuron.2021.11.023","volume":"110","author":"R Bocchi","year":"2022","unstructured":"Bocchi R, Masserdotti G, G\u00f6tz M. Direct neuronal reprogramming: fast forward from new concepts toward therapeutic approaches. Neuron. 2022;110:366\u201393.","journal-title":"Neuron"},{"key":"4285_CR223","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, S\u00fcdhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463:1035\u201341.","journal-title":"Nature"},{"key":"4285_CR224","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2011.09.002","volume":"9","author":"S Marro","year":"2011","unstructured":"Marro S, Pang ZP, Yang N, Tsai MC, Qu K, Chang HY, S\u00fcdhof TC, Wernig M. Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell. 2011;9:374\u201382.","journal-title":"Cell Stem Cell"},{"key":"4285_CR225","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.stem.2011.09.011","volume":"9","author":"J Kim","year":"2011","unstructured":"Kim J, Su SC, Wang H, Cheng AW, Cassady JP, Lodato MA, Lengner CJ, Chung CY, Dawlaty MM, Tsai LH, Jaenisch R. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell. 2011;9:413\u20139.","journal-title":"Cell Stem Cell"},{"key":"4285_CR226","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature10284","volume":"476","author":"M Caiazzo","year":"2011","unstructured":"Caiazzo M, Dell\u2019Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, Sotnikova TD, Menegon A, Roncaglia P, Colciago G, Russo G, Carninci P, Pezzoli G, Gainetdinov RR, Gustincich S. Dityatev A and broccoli V. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011;476:224\u20137.","journal-title":"Nature"},{"key":"4285_CR227","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.stem.2012.05.018","volume":"11","author":"KL Ring","year":"2012","unstructured":"Ring KL, Tong LM, Balestra ME, Javier R, Andrews-Zwilling Y, Li G, Walker D, Zhang WR, Kreitzer AC, Huang Y. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell. 2012;11:100\u20139.","journal-title":"Cell Stem Cell"},{"key":"4285_CR228","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/cr.2011.175","volume":"22","author":"C Sheng","year":"2012","unstructured":"Sheng C, Zheng Q, Wu J, Xu Z, Wang L, Li W, Zhang H, Zhao XY, Liu L, Wang Z, Guo C, Wu HJ, Liu Z, Wang L, He S, Wang XJ, Chen Z, Zhou Q. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors. Cell Res. 2012;22:208\u201318.","journal-title":"Cell Res"},{"key":"4285_CR229","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.stem.2015.06.003","volume":"17","author":"X Li","year":"2015","unstructured":"Li X, Zuo X, Jing J, Ma Y, Wang J, Liu D, Zhu J, Du X, Xiong L, Du Y, Xu J, Xiao X, Wang J, Chai Z, Zhao Y, Deng H. Small-Molecule-Driven direct reprogramming of mouse fibroblasts into functional neurons. Cell Stem Cell. 2015;17:195\u2013203.","journal-title":"Cell Stem Cell"},{"key":"4285_CR230","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/cr.2014.32","volume":"24","author":"L Cheng","year":"2014","unstructured":"Cheng L, Hu W, Qiu B, Zhao J, Yu Y, Guan W, Wang M, Yang W, Pei G. Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res. 2014;24:665\u201379.","journal-title":"Cell Res"},{"key":"4285_CR231","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2016.03.020","volume":"18","author":"M Zhang","year":"2016","unstructured":"Zhang M, Lin YH, Sun YJ, Zhu S, Zheng J, Liu K, Cao N, Li K, Huang Y, Ding S. Pharmacological reprogramming of fibroblasts into neural stem cells by Signaling-Directed transcriptional activation. Cell Stem Cell. 2016;18:653\u201367.","journal-title":"Cell Stem Cell"},{"key":"4285_CR232","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.stem.2015.07.006","volume":"17","author":"W Hu","year":"2015","unstructured":"Hu W, Qiu B, Guan W, Wang Q, Wang M, Li W, Gao L, Shen L, Huang Y, Xie G, Zhao H, Jin Y, Tang B, Yu Y, Zhao J, Pei G. Direct conversion of normal and Alzheimer\u2019s disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell. 2015;17:204\u201312.","journal-title":"Cell Stem Cell"},{"key":"4285_CR233","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.stem.2015.09.012","volume":"17","author":"L Zhang","year":"2015","unstructured":"Zhang L, Yin JC, Yeh H, Ma NX, Lee G, Chen XA, Wang Y, Lin L, Chen L, Jin P, Wu GY, Chen G. Small molecules efficiently reprogram human astroglial cells into functional neurons. Cell Stem Cell. 2015;17:735\u201347.","journal-title":"Cell Stem Cell"},{"key":"4285_CR234","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.stemcr.2019.01.003","volume":"12","author":"JC Yin","year":"2019","unstructured":"Yin JC, Zhang L, Ma NX, Wang Y, Lee G, Hou XY, Lei ZF, Zhang FY, Dong FP, Wu GY, Chen G. Chemical conversion of human fetal astrocytes into neurons through modulation of multiple signaling pathways. Stem Cell Rep. 2019;12:488\u2013501.","journal-title":"Stem Cell Rep"},{"key":"4285_CR235","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41421-021-00243-8","volume":"7","author":"Y Ma","year":"2021","unstructured":"Ma Y, Xie H, Du X, Wang L, Jin X, Zhang Q, Han Y, Sun S, Wang L, Li X, Zhang C, Wang M, Li C, Xu J, Huang Z, Wang X, Chai Z, Deng H. In vivo chemical reprogramming of astrocytes into neurons. Cell Discov. 2021;7:12.","journal-title":"Cell Discov"},{"key":"4285_CR236","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1073\/pnas.1105135108","volume":"108","author":"U Pfisterer","year":"2011","unstructured":"Pfisterer U, Kirkeby A, Torper O, Wood J, Nelander J, Dufour A, Bj\u00f6rklund A, Lindvall O, Jakobsson J, Parmar M. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A. 2011;108:10343\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4285_CR237","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/cr.2011.181","volume":"22","author":"X Liu","year":"2012","unstructured":"Liu X, Li F, Stubblefield EA, Blanchard B, Richards TL, Larson GA, He Y, Huang Q, Tan AC, Zhang D, Benke TA, Sladek JR, Zahniser NR, Li CY. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 2012;22:321\u201332.","journal-title":"Cell Res"},{"key":"4285_CR238","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ, Citri A, Sebastiano V, Marro S, S\u00fcdhof TC, Wernig M. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476:220\u20133.","journal-title":"Nature"},{"key":"4285_CR239","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.stem.2011.07.002","volume":"9","author":"R Ambasudhan","year":"2011","unstructured":"Ambasudhan R, Talantova M, Coleman R, Yuan X, Zhu S, Lipton SA, Ding S. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell. 2011;9:113\u20138.","journal-title":"Cell Stem Cell"},{"key":"4285_CR240","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature10323","volume":"476","author":"AS Yoo","year":"2011","unstructured":"Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, Lee-Messer C, Dolmetsch RE, Tsien RW, Crabtree GR. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011;476:228\u201331.","journal-title":"Nature"},{"key":"4285_CR241","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.stem.2011.07.014","volume":"9","author":"EY Son","year":"2011","unstructured":"Son EY, Ichida JK, Wainger BJ, Toma JS, Rafuse VF, Woolf CJ, Eggan K. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell. 2011;9:205\u201318.","journal-title":"Cell Stem Cell"},{"key":"4285_CR242","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ceb.2019.06.002","volume":"61","author":"A Ofenbauer","year":"2019","unstructured":"Ofenbauer A, Tursun B. Strategies for in vivo reprogramming. Curr Opin Cell Biol. 2019;61:9\u201315.","journal-title":"Curr Opin Cell Biol"},{"key":"4285_CR243","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.cell.2016.08.055","volume":"166","author":"D Srivastava","year":"2016","unstructured":"Srivastava D, DeWitt N. In vivo cellular reprogramming: the next generation. Cell. 2016;166:1386\u201396.","journal-title":"Cell"},{"key":"4285_CR244","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1073\/pnas.1303829110","volume":"110","author":"O Torper","year":"2013","unstructured":"Torper O, Pfisterer U, Wolf DA, Pereira M, Lau S, Jakobsson J, Bj\u00f6rklund A, Grealish S, Parmar M. Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci U S A. 2013;110:7038\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4285_CR245","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.stem.2013.12.001","volume":"14","author":"Z Guo","year":"2014","unstructured":"Guo Z, Zhang L, Wu Z, Chen Y, Wang F, Chen G. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer\u2019s disease model. Cell Stem Cell. 2014;14:188\u2013202.","journal-title":"Cell Stem Cell"},{"key":"4285_CR246","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.stem.2023.08.001","volume":"30","author":"J Wang","year":"2023","unstructured":"Wang J, Sun S, Deng H. Chemical reprogramming for cell fate manipulation: methods, applications, and perspectives. Cell Stem Cell. 2023;30:1130\u201347.","journal-title":"Cell Stem Cell"},{"key":"4285_CR247","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.neuron.2016.08.004","volume":"91","author":"H Li","year":"2016","unstructured":"Li H, Chen G. In vivo reprogramming for CNS repair: regenerating neurons from endogenous glial cells. Neuron. 2016;91:728\u201338.","journal-title":"Neuron"},{"key":"4285_CR248","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1007\/s00018-019-03193-3","volume":"76","author":"M Pereira","year":"2019","unstructured":"Pereira M, Birtele M, Rylander Ottosson D. Direct reprogramming into interneurons: potential for brain repair. Cell Mol Life Sci. 2019;76:3953\u201367.","journal-title":"Cell Mol Life Sci"},{"key":"4285_CR249","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","volume":"167","author":"A Ocampo","year":"2016","unstructured":"Ocampo A, Reddy P, Martinez-Redondo P, Platero-Luengo A, Hatanaka F, Hishida T, Li M, Lam D, Kurita M, Beyret E, Araoka T, Vazquez-Ferrer E, Donoso D, Roman JL, Xu J, Rodriguez Esteban C, Nu\u00f1ez G, Nu\u00f1ez Delicado E, Campistol JM, Guillen I, Guillen P, Izpisua Belmonte JC. In vivo amelioration of Age-Associated hallmarks by partial reprogramming. Cell. 2016;167:1719\u2013e173312.","journal-title":"Cell"},{"key":"4285_CR250","doi-asserted-by":"crossref","unstructured":"Singh PB, Zhakupova A. Age reprogramming: cell rejuvenation by partial reprogramming. Development. 2022;149.","DOI":"10.1242\/dev.200755"},{"key":"4285_CR251","doi-asserted-by":"crossref","unstructured":"Gill D, Parry A, Santos F, Okkenhaug H, Todd CD, Hernando-Herraez I, Stubbs TM, Milagre I, Reik W. Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. Elife. 2022;11.","DOI":"10.7554\/eLife.71624"},{"key":"4285_CR252","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41467-020-15174-3","volume":"11","author":"TJ Sarkar","year":"2020","unstructured":"Sarkar TJ, Quarta M, Mukherjee S, Colville A, Paine P, Doan L, Tran CM, Chu CR, Horvath S, Qi LS, Bhutani N. Rando TA and Sebastiano V. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat Commun. 2020;11:1545.","journal-title":"Nat Commun"},{"key":"4285_CR253","doi-asserted-by":"crossref","unstructured":"Browder KC, Reddy P, Yamamoto M, Haghani A, Guillen IG, Sahu S, Wang C, Luque Y, Prieto J, Shi L, Shojima K, Hishida T, Lai Z, Li Q, Choudhury FK, Wong WR, Liang Y, Sangaraju D, Sandoval W, Esteban CR, Delicado EN, Garcia PG, Pawlak M, Vander Heiden JA, Horvath S, Jasper H and Izpisua, Belmonte JC. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nat Aging. 2022;2:243\u2013253.","DOI":"10.1038\/s43587-022-00183-2"},{"key":"4285_CR254","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1038\/s41467-021-23353-z","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C, Rabadan Ros R, Martinez-Redondo P, Ma Z, Shi L, Xue Y, Guillen-Guillen I, Huang L, Hishida T, Liao HK, Nu\u00f1ez Delicado E, Rodriguez Esteban C, Guillen-Garcia P, Reddy P, Izpisua Belmonte JC. In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche. Nat Commun. 2021;12:3094.","journal-title":"Nat Commun"},{"key":"4285_CR255","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.cels.2022.05.002","volume":"13","author":"AE Roux","year":"2022","unstructured":"Roux AE, Zhang C, Paw J, Zavala-Solorio J, Malahias E, Vijay T, Kolumam G, Kenyon C, Kimmel JC. Diverse partial reprogramming strategies restore youthful gene expression and transiently suppress cell identity. Cell Syst. 2022;13:574\u2013e58711.","journal-title":"Cell Syst"},{"key":"4285_CR256","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41467-024-46020-5","volume":"15","author":"AD Y\u00fccel","year":"2024","unstructured":"Y\u00fccel AD, Gladyshev VN. The long and winding road of reprogramming-induced rejuvenation. Nat Commun. 2024;15:1941.","journal-title":"Nat Commun"},{"key":"4285_CR257","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/cell.2023.0072","volume":"26","author":"CC Macip","year":"2024","unstructured":"Macip CC, Hasan R, Hoznek V, Kim J, Lu YR, Metzger LEt, Sethna S, Davidsohn N. Gene Therapy-Mediated partial reprogramming extends lifespan and reverses Age-Related changes in aged mice. Cell Reprogram. 2024;26:24\u201332.","journal-title":"Cell Reprogram"},{"key":"4285_CR258","doi-asserted-by":"crossref","unstructured":"Cho HE, Lee S, Seo JH, Kang SW, Choi WA, Cho SR. In vivo reprogramming using Yamanaka factors in the CNS: A scoping review. Cells. 2024;13.","DOI":"10.3390\/cells13040343"},{"key":"4285_CR259","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/cell.2023.0123","volume":"26","author":"AS Sichani","year":"2024","unstructured":"Sichani AS, Khoddam S, Shakeri S, Tavakkoli Z, Jafroodi AR, Dabbaghipour R, Sisakht M, Fallahi J. Partial reprogramming as a method for regenerating neural tissues in aged organisms. Cell Reprogram. 2024;26:10\u201323.","journal-title":"Cell Reprogram"},{"key":"4285_CR260","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s43587-021-00109-4","volume":"1","author":"B Neumann","year":"2021","unstructured":"Neumann B, Segel M, Ghosh T, Zhao C, Tourlomousis P, Young A, F\u00f6rster S, Sharma A, Chen CZ, Cubillos JF, Rawji KS, Chalut KJ, Franklin RJM. Myc determines the functional age state of oligodendrocyte progenitor cells. Nat Aging. 2021;1:826\u201337.","journal-title":"Nat Aging"},{"key":"4285_CR261","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.stemcr.2020.09.010","volume":"15","author":"A Rodr\u00edguez-Matell\u00e1n","year":"2020","unstructured":"Rodr\u00edguez-Matell\u00e1n A, Alcazar N, Hern\u00e1ndez F, Serrano M, \u00c1vila J. In vivo reprogramming ameliorates aging features in dentate gyrus cells and improves memory in mice. Stem Cell Rep. 2020;15:1056\u201366.","journal-title":"Stem Cell Rep"},{"key":"4285_CR262","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-020-2975-4","volume":"588","author":"Y Lu","year":"2020","unstructured":"Lu Y, Brommer B, Tian X, Krishnan A, Meer M, Wang C, Vera DL, Zeng Q, Yu D, Bonkowski MS, Yang JH, Zhou S, Hoffmann EM, Karg MM, Schultz MB, Kane AE, Davidsohn N, Korobkina E, Chwalek K, Rajman LA, Church GM, Hochedlinger K, Gladyshev VN, Horvath S, Levine ME, Gregory-Ksander MS, Ksander BR, He Z, Sinclair DA. Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020;588:124\u20139.","journal-title":"Nature"},{"key":"4285_CR263","doi-asserted-by":"crossref","unstructured":"Shen Y, Zaballa S, Bech X, Sancho-Balsells A, D\u00edaz-Cifuentes C, Seyit-Bremer G, Ballasch I, Alc\u00e1zar N, Alberch J, Abad M, Serrano M, Klein R. Giralt A and del Toro D. Expansion of the neocortex and protection from neurodegeneration by <\u2009em\u2009>\u2009in vivo\u2009transient reprogramming. bioRxiv. 2023:2023.11.27.568858.","DOI":"10.2139\/ssrn.4647293"},{"key":"4285_CR264","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/mt.2016.124","volume":"24","author":"JH Seo","year":"2016","unstructured":"Seo JH, Lee MY, Yu JH, Kim MS, Song M, Seo CH. Kim HH and cho SR. In situ pluripotency factor expression promotes functional recovery from cerebral ischemia. Mol Ther. 2016;24:1538\u201349.","journal-title":"Mol Ther"},{"key":"4285_CR265","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s43587-024-00594-3","volume":"4","author":"L Xu","year":"2024","unstructured":"Xu L, Ramirez-Matias J, Hauptschein M, Sun ED, Lunger JC, Buckley MT, Brunet A. Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche. Nat Aging. 2024;4:546\u201367.","journal-title":"Nat Aging"},{"key":"4285_CR266","doi-asserted-by":"publisher","first-page":"e1004476","DOI":"10.1371\/journal.pcbi.1004476","volume":"11","author":"T Miyamoto","year":"2015","unstructured":"Miyamoto T, Furusawa C, Kaneko K. Pluripotency, differentiation, and reprogramming: A gene expression dynamics model with epigenetic feedback regulation. PLoS Comput Biol. 2015;11:e1004476.","journal-title":"PLoS Comput Biol"},{"key":"4285_CR267","doi-asserted-by":"crossref","unstructured":"Mosteiro L, Pantoja C, Alcazar N, Mari\u00f3n RM, Chondronasiou D, Rovira M, Fernandez-Marcos PJ, Mu\u00f1oz-Martin M, Blanco-Aparicio C, Pastor J, G\u00f3mez-L\u00f3pez G, De Martino A, Blasco MA, Abad M, Serrano M. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science. 2016;354.","DOI":"10.1126\/science.aaf4445"},{"key":"4285_CR268","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2014.01.005","volume":"156","author":"K Ohnishi","year":"2014","unstructured":"Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, Yamada Y. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 2014;156:663\u201377.","journal-title":"Cell"},{"key":"4285_CR269","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature12586","volume":"502","author":"M Abad","year":"2013","unstructured":"Abad M, Mosteiro L, Pantoja C, Ca\u00f1amero M, Rayon T, Ors I, Gra\u00f1a O, Meg\u00edas D, Dom\u00ednguez O, Mart\u00ednez D, Manzanares M, Ortega S, Serrano M. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature. 2013;502:340\u20135.","journal-title":"Nature"},{"key":"4285_CR270","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/stem.1011","volume":"30","author":"J Ji","year":"2012","unstructured":"Ji J, Ng SH, Sharma V, Neculai D, Hussein S, Sam M, Trinh Q, Church GM, McPherson JD, Nagy A, Batada NN. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells. 2012;30:435\u201340.","journal-title":"Stem Cells"},{"key":"4285_CR271","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.ymthe.2021.04.007","volume":"29","author":"M Kosanke","year":"2021","unstructured":"Kosanke M, Osetek K, Haase A, Wiehlmann L, Davenport C, Schwarzer A, Adams F, Kleppa MJ, Schambach A, Merkert S, Wunderlich S, Menke S, Dorda M, Martin U. Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes. Mol Ther. 2021;29:2535\u201353.","journal-title":"Mol Ther"},{"key":"4285_CR272","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/s43587-023-00528-5","volume":"3","author":"A Parras","year":"2023","unstructured":"Parras A, V\u00edlchez-Acosta A, Desd\u00edn-Mic\u00f3 G, Pic\u00f3 S, Mrabti C, Montenegro-Borbolla E, Maroun CY, Haghani A, Brooke R, Del Carmen Maza M, Rechsteiner C, Battiston F, Branchina C, Perez K, Horvath S, Bertelli C. Sempoux C and Ocampo A. In vivo reprogramming leads to premature death linked to hepatic and intestinal failure. Nat Aging. 2023;3:1509\u201320.","journal-title":"Nat Aging"},{"key":"4285_CR273","doi-asserted-by":"publisher","first-page":"eadi8454","DOI":"10.1126\/sciadv.adi8454","volume":"9","author":"J Kim","year":"2023","unstructured":"Kim J, Kim S, Lee SY, Jo BK, Oh JY, Kwon EJ, Kim KT, Adpaikar AA, Kim EJ, Jung HS, Kim HR, Roe JS, Hong CP, Kim JK, Koo BK, Cha HJ. Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous Ptgs1 induction. Sci Adv. 2023;9:eadi8454.","journal-title":"Sci Adv"},{"key":"4285_CR274","doi-asserted-by":"crossref","unstructured":"Baldari S, Di Rocco G, Piccoli M, Pozzobon M, Muraca M, Toietta G. Challenges and strategies for improving the regenerative effects of mesenchymal stromal Cell-Based therapies. Int J Mol Sci. 2017;18.","DOI":"10.3390\/ijms18102087"},{"key":"4285_CR275","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cjca.2014.03.021","volume":"30","author":"A Ludke","year":"2014","unstructured":"Ludke A, Li RK, Weisel RD. The rejuvenation of aged stem cells for cardiac repair. Can J Cardiol. 2014;30:1299\u2013306.","journal-title":"Can J Cardiol"},{"key":"4285_CR276","doi-asserted-by":"crossref","unstructured":"Pettitt D, Holl\u00e4nder G, Brindley D. 718. Cell therapy commercialization: an assessment of translational barriers. Mol Ther. 2016;24.","DOI":"10.1016\/S1525-0016(16)33526-2"},{"key":"4285_CR277","doi-asserted-by":"publisher","first-page":"204062072090600","DOI":"10.1177\/2040620720906002","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yang F, Feng S. Allogeneic hematopoietic stem-cell transplantation for myelofibrosis. Ther Adv Hematol. 2020;11:2040620720906002.","journal-title":"Ther Adv Hematol"},{"key":"4285_CR278","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-018-0744-4","volume":"564","author":"BA Biddy","year":"2018","unstructured":"Biddy BA, Kong W, Kamimoto K, Guo C, Waye SE, Sun T, Morris SA. Single-cell mapping of lineage and identity in direct reprogramming. Nature. 2018;564:219\u201324.","journal-title":"Nature"},{"key":"4285_CR279","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1166\/jbn.2017.2347","volume":"13","author":"J Yoo","year":"2017","unstructured":"Yoo J, Chang Y, Kim H, Baek S, Choi H, Jeong GJ, Shin J, Kim H, Kim BS, Kim J. Efficient direct lineage reprogramming of fibroblasts into induced cardiomyocytes using nanotopographical cues. J Biomed Nanotechnol. 2017;13:269\u201379.","journal-title":"J Biomed Nanotechnol"},{"key":"4285_CR280","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biomaterials.2014.12.049","volume":"45","author":"J Yoo","year":"2015","unstructured":"Yoo J, Noh M, Kim H, Jeon NL, Kim BS, Kim J. Nanogrooved substrate promotes direct lineage reprogramming of fibroblasts to functional induced dopaminergic neurons. Biomaterials. 2015;45:36\u201345.","journal-title":"Biomaterials"},{"key":"4285_CR281","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/stem.2284","volume":"34","author":"N Knappe","year":"2016","unstructured":"Knappe N, Novak D, Weina K, Bernhardt M, Reith M, Larribere L, H\u00f6lzel M, T\u00fcting T, Gebhardt C. Umansky V and Utikal J. Directed dedifferentiation using partial reprogramming induces invasive phenotype in melanoma cells. Stem Cells. 2016;34:832\u201346.","journal-title":"Stem Cells"},{"key":"4285_CR282","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21037\/mps-20-3","volume":"4","author":"Y Huang","year":"2020","unstructured":"Huang Y, Wang T, L\u00f3pez MEU, Hirano M, Hasan A, Shin SR. Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration. Microphysiol Syst. 2020;4:2.","journal-title":"Microphysiol Syst"},{"key":"4285_CR283","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1378\/chest.14-1696","volume":"147","author":"J Lowenthal","year":"2015","unstructured":"Lowenthal J, Sugarman J. Ethics and policy issues for stem cell research and pulmonary medicine. Chest. 2015;147:824\u201334.","journal-title":"Chest"},{"key":"4285_CR284","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.21666","volume":"15","author":"V Volarevic","year":"2018","unstructured":"Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M. Ethical and safety issues of stem Cell-Based therapy. Int J Med Sci. 2018;15:36\u201345.","journal-title":"Int J Med Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04285-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04285-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04285-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:52:26Z","timestamp":1743969146000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04285-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,6]]},"references-count":284,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4285"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04285-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,6]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"167"}}